US20130333796A1 - Device with penetrable septum, filling needle and penetrable closure, and related method - Google Patents
Device with penetrable septum, filling needle and penetrable closure, and related method Download PDFInfo
- Publication number
- US20130333796A1 US20130333796A1 US13/917,562 US201313917562A US2013333796A1 US 20130333796 A1 US20130333796 A1 US 20130333796A1 US 201313917562 A US201313917562 A US 201313917562A US 2013333796 A1 US2013333796 A1 US 2013333796A1
- Authority
- US
- United States
- Prior art keywords
- septum
- closure
- penetrable
- penetrable septum
- filling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000011049 filling Methods 0.000 title claims description 260
- 238000000034 method Methods 0.000 title claims description 45
- 238000002347 injection Methods 0.000 claims abstract description 94
- 239000007924 injection Substances 0.000 claims abstract description 94
- 239000012530 fluid Substances 0.000 claims abstract description 64
- 239000000126 substance Substances 0.000 claims abstract description 58
- 238000004891 communication Methods 0.000 claims abstract description 28
- 238000007789 sealing Methods 0.000 claims description 43
- 230000000149 penetrating effect Effects 0.000 claims description 33
- 230000035515 penetration Effects 0.000 claims description 27
- 230000001954 sterilising effect Effects 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 15
- 230000036512 infertility Effects 0.000 claims description 12
- 230000005855 radiation Effects 0.000 claims description 11
- 230000009467 reduction Effects 0.000 claims description 9
- 239000004033 plastic Substances 0.000 claims description 6
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 2
- 239000013013 elastic material Substances 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 description 20
- 239000000356 contaminant Substances 0.000 description 16
- 238000013022 venting Methods 0.000 description 14
- 238000004659 sterilization and disinfection Methods 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 230000006835 compression Effects 0.000 description 9
- 238000007906 compression Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 6
- 238000011109 contamination Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000012859 sterile filling Methods 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 229920000106 Liquid crystal polymer Polymers 0.000 description 4
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- 229920001169 thermoplastic Polymers 0.000 description 4
- 239000004416 thermosoftening plastic Substances 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920013683 Celanese Polymers 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- 239000004636 vulcanized rubber Substances 0.000 description 2
- 238000012371 Aseptic Filling Methods 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- -1 vaccines Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
- A61J1/1425—Snap-fit type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2251/00—Details relating to container closures
- B65D2251/0003—Two or more closures
- B65D2251/0006—Upper closure
- B65D2251/0015—Upper closure of the 41-type
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2251/00—Details relating to container closures
- B65D2251/0003—Two or more closures
- B65D2251/0068—Lower closure
- B65D2251/009—Lower closure of the 51-type
Definitions
- the present invention relates to a device, such as a container, vial or dispenser, with a septum that is penetrable for filling a chamber with a substance therethrough, a closure that closes the penetrated septum and is itself penetrable for accessing the substance filled into the chamber, and a filling device for filling the chamber through the septum, and related methods.
- a device such as a container, vial or dispenser, with a septum that is penetrable for filling a chamber with a substance therethrough, a closure that closes the penetrated septum and is itself penetrable for accessing the substance filled into the chamber, and a filling device for filling the chamber through the septum, and related methods.
- a typical previously-known vial having a penetrable septum for filling therethrough leaves a residual injection aperture in the septum after a filling needle penetrates and withdraws therefrom.
- Hermetically resealing the penetrated septum requires utilizing an external source such as radiation or chemicals. While such methods are effective, one drawback is that radiation or chemical resealing requires relatively expensive parts in a filling assembly line.
- a typical previously-known filling needle includes a hollow stainless steel shaft, a non-coring, conically-pointed tip fixedly secured to the distal end of the shaft, and diametrically opposed fluid ports proximal to the tip and in fluid communication between the interior of the shaft and the ambient environment.
- One drawback encountered with previously-known filling needles is that the interior of the needle, and any fluid contained therein or passing therethrough, can be exposed to the ambient environment via the open fluid ports.
- regulatory agencies require control of the filling needle environment in order to protect against exposure of a sterile product to the environment and the resulting contamination of the product that might occur.
- typical controlled environments such as a class 100 (ISO-5) controlled environment, are not truly sterile.
- a device comprises a sealed chamber; a first penetrable septum in fluid communication with the chamber that is penetrable by a first needle or like injection member to fill the first chamber with a substance therethrough; and a second penetrable septum.
- the second penetrable septum is movable between first and second positions. In the first position, at least a portion of the second septum is spaced away from the first septum to allow the needle or like injection member to penetrate the first septum and aseptically or sterile fill the chamber with a substance therethrough.
- said at least a portion of the second septum overlies and mechanically seals a resulting injection aperture in the first septum after withdrawal of the first needle or like injection member therefrom, and is penetrable by a second needle to penetrate the first and second septums and withdraw a filled substance from the chamber.
- the device further comprises a body defining the chamber and a first closure connected to the body and forming a fluid-tight seal therebetween.
- the first closure includes the first penetrable septum.
- the device further comprises a second closure connectable to the first closure and/or body.
- the second closure includes the second penetrable septum.
- the first and/or second penetrable septums are co-molded with the first and second closures, respectively.
- the first penetrable septum is over-molded onto the first closure, and the second penetrable septum is over-molded onto the second closure.
- the first and/or second penetrable septums are over-molded to the first and second closures, respectively, at the same time.
- the second closure is connected to the first closure, and at least one of the first and second closures is movable relative to the other to position the second closure in the first or second positions.
- the device further comprises a hinge coupled between the first and second closures to allow movement of the second closure from the first open position to the second closed position.
- the hinge is a living hinge.
- the first and second closures are injection molded as one part, and the first and second penetrable septums are over-molded to the first and second closures, respectively.
- the first penetrable septum is formed of an elastic material.
- the aperture formed in the first penetrable septum by the needle, injection or filling member substantially closes upon withdrawal of the needle, injection or filling member due to the elastic properties of the material.
- the material is sufficiently elastic to substantially hermetically seal itself at a resulting penetration aperture after withdrawal of the first needle or like injection member therefrom.
- the first septum is approximately dome or convex shaped. In some such embodiments, the first septum is approximately dome or convex shaped on a side thereof substantially opposite the side of the chamber.
- the second penetrable septum is approximately dome or convex shaped. In some such embodiments, the second septum is approximately dome or convex shaped on a side thereof substantially opposite or juxtaposed with respect to the upper side of the first septum in a way that the second septum and first septum provide a mechanical seal around an aperture left by a filling needle.
- the first septum comprises a substantially homogeneous material, such as, for example, silicone.
- the first septum defines a durometer within the range of about 5 Shore A to about 65 Shore A, such as within the range of about 25 Shore A to about 45 Shore A.
- the first septum defines a thickness within the range about 1 ⁇ 2 to about twice the largest diameter of the needle or like injection member that penetrates the first septum to fill a chamber therethrough.
- penetration of the first septum by the first needle or like injection member achieves at least about a 3 log reduction in bio-burden by wiping the tip of the first needle or like injection member. In some such embodiments, penetration of the first septum by the first needle or like injection member achieves at least about a 6 log reduction in bio-burden of the tip.
- the first closure includes a first connecting member
- the second closure includes a second connecting member
- at least one of the first and second connecting members is engageable with the other to secure the second penetrable septum in the second position.
- at least one of the first and second connecting members is receivable within the other to secure the second penetrable septum in the second position.
- the first connecting member defines a recess
- the second connector member defines a protrusion receivable within the recess to secure the second penetrable septum in the second position.
- the protrusion defines a chamfer or beveled surface slideable against the recess to facilitate inserting the second connecting member into the first connector member.
- the protrusion is engageable with an underside of the recess to secure the second connecting member to the first connecting member.
- the recess extends angularly about the first connecting member, and the protrusion extends angularly about the second connecting member.
- the second penetrable septum is entirely spaced away from the first penetrable septum in the first position.
- the device further comprises a body defining the chamber and a closure overlying the first penetrable septum and connected to the body and forming a fluid-tight seal therebetween.
- the second penetrable septum is slidably received in the closure.
- the device further comprises a disk including the second penetrable septum.
- the closure further defines a lateral slot therein for slidably receiving the disk therein, wherein the disk creates a dimensional interference fit with the slot, thereby creating a sliding, fluid-tight seal, therebetween.
- the second septum comprises a first portion and a second portion, wherein said second portion defines said at least a portion of the second septum.
- the first portion of the second septum sealingly overlies the first septum and the second portion of the second septum is spaced away from the first septum.
- the second portion of the second septum sealingly overlies the first septum and the first portion of the second septum is spaced away from the first septum.
- a device comprises a sealed chamber; first means in fluid communication with the chamber and penetrable by a first needle or like injection member for filling the first chamber with a substance therethrough; and second means movable between a first position, wherein at least a portion of the second means is spaced away from the first means for allowing the first needle or like injection member to penetrate the first means and fill the chamber therethrough, and a second position for sealing a resulting injection aperture in the first means after withdrawal of the first needle or like injection member therefrom, and penetrable by a second needle or like injection member for penetrating the first and second means and withdrawing a filled substance from the chamber and through the second needle or like injection member.
- the first means is formed of an elastic material. In some embodiments, the first means is a first penetrable septum, and the second means is a second penetrable septum.
- a device comprises a sealed chamber, and a penetrable septum, having a first portion and a second portion, in fluid communication with the chamber.
- the penetrable septum is movable between (i) a first position, wherein the first portion is in fluid communication with the chamber to allow a first needle or like injection member to penetrate therethrough, and, in turn, fill the chamber with substance, and (ii) a second position, wherein the second, unpenetrated portion, sealingly overlies the chamber after withdrawal of the first needle or like injection member therefrom.
- the second portion is penetrable in the second position by a second needle or like injection member to, in turn, withdraw substance from the chamber.
- the device further comprises a body defining the chamber and a closure connected to the body and forming a fluid-tight seal therebetween, wherein the penetrable septum is slidably received in the closure.
- the device further comprises a disk including the penetrable septum.
- the closure further defines a lateral slot therein for slidably receiving the disk therein, wherein the disk creates a dimensional interference fit with the slot, thereby creating a sliding, fluid-tight seal, therebetween.
- a filling device comprises a hollow filling member.
- a tip is formed at one end of the filling member, at least one port is in fluid communication with the interior of the hollow filling member, and an annular shell extends radially and angularly about the filling member.
- a closure is coupled to the annular shell, and at least one of the closure and the filling member is movable between (i) a first position wherein the closure closes the at least one port and forms a substantially fluid-tight seal between the fluid port and ambient atmosphere to facilitate maintaining sterility of the port and interior of the filling member, and (ii) a second position opening the at least one port and allowing a flow of substance through the port.
- the closure is biased in a direction from the second position toward the first position to normally close the at least one port.
- the filling device further comprises a biasing member biasing the closure in the direction from the second position toward the first position.
- the closure is engageable with a penetrable septum to move at least one of the closure and filling member from the first position to the second position upon penetrating the septum with tip of the filling member. In some embodiments, at least one of the closure and filling member is movable from the second position to the first position during or upon withdrawing the filling member from the septum.
- a distal end of the closure is engageable with a stop surface of the filling member to stop the closure in the first position and form a substantially fluid-tight seal between the closure and filling member.
- the filling device further comprises a sealing member located between the distal end of the closure and the stop surface and forming a substantially fluid-tight seal therebetween in the first position.
- the sealing member is integrally molded, such as by over molding, to the closure. In other embodiments, the sealing member is integrally molded, such as by over molding, to the stop surface.
- the filling member is formed of plastic, such as any of numerous different thermoplastics, including the liquid crystal polymers (LCP) that are highly crystalline, thermotropic (melt-orienting) thermoplastics and sold under the trademark VECTRATM by Celanese Corporation.
- LCP liquid crystal polymers
- VECTRATM thermotropic (melt-orienting) thermoplastics
- the annular shell forms a bellows.
- the annular shell includes a one-way valve in fluid communication between the hollow filling member and ambient atmosphere.
- the one-way valve vents out air and/or other gases from within the shell to the ambient atmosphere when the bellows is under compression.
- a filling device comprises first means for providing a conduit for the passage of fluid therethrough; second means formed at one end of the first means for penetrating a septum; third means in fluid communication with the conduit for passage of fluid from the conduit therethrough; and fourth means for closing the third means. At least one of the fourth means and the first means is movable between (i) a first position wherein the fourth means closes the third means and forms a substantially fluid-tight seal between the third means and ambient atmosphere to facilitate maintaining sterility of the third means and an interior of the first means, and (ii) a second position opening the third means.
- Some embodiments further comprise fifth means for forming a seal between the fourth means and at least one of the first and second means.
- the first means comprises a filling member
- the second means comprises a tip of the filling member
- the third means comprises at least one port
- the fourth means comprises a closure
- the fifth means comprises a sealing member
- a method comprises the following steps:
- the method further comprises the steps of:
- the method further comprises, prior to closing a resulting penetration aperture in the first septum with the second septum, sterilizing at least an exterior surface of the first penetrable septum defining the resulting penetration aperture and an interior surface of the second penetrable septum, such as with UV radiation (e.g., at a wavelength of about 254 nm), or low energy beta radiation, or by any sterilizing agent.
- the sterilizing step includes applying radiation to said surfaces.
- the step of sterilizing the sealed empty chamber is performed prior to penetrating the first penetrable septum.
- the penetrating step further comprises wiping the first needle or like injection member with the first penetrable septum.
- the wiping step comprises wiping the tip of the filling needle or like injection member with the first penetrable septum.
- the wiping step comprises wiping the needle or like injection member with the first penetrable septum defining a durometer within the range of about 5 Shore A to about 65 Shore A.
- the wiping step comprises wiping the needle or like injection member with the first penetrable septum defining a thickness within the range of about 1 ⁇ 2 to about two times the largest diameter of the needle or like injection member.
- the wiping step comprises wiping the tip of the needle or like injection member, wherein the tip defines an included bevel angle within the range of about 30 degrees to about 50 degrees, such as about 40 degrees. In some such embodiments, the wiping step achieves at least about a 3 log reduction in bio-burden on the tip of the needle or like injection member.
- the sealing step includes moving the second penetrable septum from a first position, wherein a first portion thereof overlies the first penetrable septum, to a second position, wherein a second portion thereof overlies and sealingly engages the first penetrable septum. In other embodiments, the sealing step includes moving the second penetrable septum from a first position spaced away from the first penetrable septum to a second position overlying and sealingly engaging the first penetrable septum.
- a method comprises the following steps:
- the substance can be introduced from the first needle or like injection member into the chamber after full perforation of the first penetrable septum or after part of the at least one filling port has passed through an interior surface of the first penetrable septum and is located within the chamber.
- the method can further comprise the step of substantially sealing the at least one filling port and an interior of the needle or like injection member from ambient atmosphere in the closed position.
- the method can also comprise, before or during the withdrawing step, moving at least one of the closure and the at least one filling port of the first needle or like injection member from the open position to the closed position.
- the method can include substantially preventing any contact between the at least one filling port and the first penetrable septum.
- the closure is interposed between the at least one filling port and first penetrable septum to substantially prevent any contact between the at least one filling port and the first penetrable septum.
- the device such as a container to be filled
- the present invention obviates the need to thermally, chemically or laser reseal the resulting penetration aperture, and thus obviates the need for such additional processing steps and equipment.
- the septum is configured to wipe the tip of the filling needle or like injection member as it penetrates the septum to fill the chamber, and effectively de-contaminates and/or sterilizes the tip prior to entry into the chamber. Accordingly, another advantage of the present invention is that it can reduce the risk of contamination and/or reduce the controls over, or the need to control a filling needle environment.
- the needle opens and closes automatically within the sterile or aseptic container.
- the needle is always closed prior to being withdrawn from within the sterile container.
- the needle is sealed during passage through the septum to prevent any contaminants on the septum or in the environment from contaminating the interior of the needle.
- FIG. 1 is a side perspective view of a device in the form of a container
- FIGS. 2A-2D sequentially show the assembly of the device of FIG. 1 , in which the septa are over-molded onto the molded cap and the first closure is sealingly closed in place on the container;
- FIG. 3A is a partial, side cross-sectional side view of the device of FIG. 1 , with the second closure in the first, non-sealing position;
- FIG. 3B is a side cross-sectional view of the device of FIG. 1 after the filling member has pierced the device septum and has been withdrawn leaving a hole in the device septum, with the second closure in the first, non-sealing position, and schematically showing sterilization of the first and second closures;
- FIG. 4 is a side cross-sectional view of the device of FIG. 1 , with the second closure in the second, sealing position;
- FIG. 5 is a side perspective view of a filling device engageable with the device of FIG. 1 to aseptically or sterile fill a substance therein;
- FIG. 6A is a side cross-sectional view of the filling device of FIG. 5 , with the closure in the first or closed position, sealing the ports of the filling member from the ambient atmosphere;
- FIG. 6B is a side cross-sectional view of the filling device of FIG. 5 , with the closure in the second or open position, opening the ports of the filling member;
- FIG. 7A is a partial, side cross-sectional view of the closure and tip of the filling device of FIG. 5 prior to engagement with the septum of the device of FIG. 1 , with the closure in the first or closed position sealing the ports from ambient atmosphere;
- FIG. 7B is a side cross-sectional view of the filling device of FIG. 5 upon penetration of the tip of the filling member through a septum of the type shown in FIG. 1 , with the closure still in the first or closed position sealing the ports from contact with the penetrated septum;
- FIG. 7C is a side cross-sectional view of the filling device of FIG. 5 , where the tip of the filling member is penetrated through the septum, the closure is prevented from further movement through the septum, and the filling member is allowed to continue to move into the chamber relative to the fixed closure to expose the fluid ports to the chamber and allow the aseptic or sterile flow of substance through the open ports and into the aseptic or sterile chamber;
- FIG. 8A is a side cross-sectional view of another embodiment of the distal end of the filling device of FIG. 5 , including a seal over-molded to the stop surface formed at the tip of the filling member to facilitate forming a substantially fluid-tight or hermetic seal between the closure and filling device;
- FIG. 8B is a side cross-sectional view of another embodiment of the distal end of the filling device of FIG. 5 , including a seal over-molded to the distal end of the closure to facilitate forming a substantially fluid-tight or hermetic seal between the closure and filling device.
- FIG. 9A is a top perspective view of a device in the form of a container, with the second closure in the first, non-sealing position;
- FIG. 9B is a top perspective view the device of FIG. 9A with the second closure in the first, non-sealing position with a filling member positioned to pierce the first closure;
- FIG. 9C is a side view of the device of FIG. 9A that has been filled, with the second closure in the second, sealing position and ready for sampling of substance in the chamber;
- FIG. 9D is a side view of the filled device of FIG. 9C with a needle piercing the second closure into the chamber to permit withdrawal and sampling of substance from the chamber;
- FIG. 9E is a side view of the device of FIG. 9C with all of the substance withdrawn from the chamber;
- FIG. 10A is a cross-sectional view of the device and filling member shown FIG. 9B ;
- FIG. 10B is a cross-sectional view of the device of FIG. 9A with the tip of the filling member penetrating the septum of the first closure into the chamber and the closure of the filling member in the first or closed position, sealing the ports of the filling member from the ambient atmosphere;
- FIG. 10C is a cross-sectional view of the device of FIG. 9A with the filling member further penetrating into the chamber with the closure of the filling member in the second or open position, opening the ports of the filling member;
- FIG. 10D is a cross-sectional view of the device of FIG. 9A with the filling member partially withdrawn from the chamber and the closure of the filling member moved back to the first or closed position, re-sealing the ports of the filling member from the ambient atmosphere;
- FIG. 11 is an exploded view of another embodiment of a device in the form of a container
- FIGS. 12A-12D show sequential side cross-sectional views of the assembly, sterilization, filling and sealing of the device of FIG. 11 taken along section line A-A;
- FIG. 13 is a perspective cross-sectional view of another embodiment of a device in the form of a container, prior to assembly of the second septum thereto;
- FIG. 14 is a perspective cross-sectional view of the device of FIG. 13 , with the second septum in a first, ready for filling, position;
- FIG. 15 is a perspective cross-sectional view of the device of FIG. 13 during filling thereof;
- FIG. 16 is a perspective cross-sectional view of the device of FIG. 13 , with the second septum in a second, sealing, position;
- FIG. 17 is a perspective cross-sectional view of another embodiment of a device in the form of a container, prior to assembly of the septum thereto;
- FIG. 18 is a perspective cross-sectional view of the device of FIG. 17 , with the septum in a first, ready for filling, position;
- FIG. 19 is a perspective cross-sectional view of the device of FIG. 17 during filling thereof;
- FIG. 20 is a perspective cross-sectional view of the device of FIG. 17 with the septum in a second, sealing, position;
- FIG. 21 is an exploded view of another embodiment of a device in the form of a container.
- FIG. 22 is a perspective side view of the device of FIG. 21 , with the closure in the first position, uncovering the filling septum;
- FIG. 23 is a perspective side view of the device of FIG. 21 , with the closure in the second position, uncovering the withdrawal septum.
- a device is indicated generally by the reference numeral 10 .
- the device 10 is a container defining a sealed (with respect to the ambient atmosphere or environment) empty chamber 11 therein for aseptic or sterile filling with a substance, such as a medicament, pharmaceutical injectable, or vaccine.
- a substance such as a medicament, pharmaceutical injectable, or vaccine.
- the invention may be embodied in and otherwise may be applicable to any of numerous different types of devices that are currently known or that later become known, such as vials, syringes, delivery devices, dispensers and processing devices.
- the devices may be filled with any of numerous different substances that are currently known or that later become known, such as medicaments, pharmaceutical injectables, vaccines, supplements, foods, beverages, liquid nutrition products, and industrial products, and in any of numerous different forms, including liquids, gels, powders and gases.
- the container 10 includes a body 12 and a closure 14 .
- the body is substantially cylindrical and defines a substantially cylindrical sidewall 16 with an opening 18 at a top end thereof, for sealingly receiving the closure 14 thereon, as described further below.
- the body 12 further includes an annular projection 20 spaced from the top end thereof and extending laterally outwardly from the sidewall 16 .
- the body 12 may be made of glass or plastic. However, as may be recognized by those of ordinary skill in the pertinent art based on the teaching herein, the body may be made of any of numerous different materials that are currently known or that later become known.
- the body may be configured in any of numerous shapes to receive a closure.
- the body may define a spool-like or “diabolo” shape such as disclosed in U.S. Pat. No. 7,100,646, issued Sep. 5, 2006, entitled “Sealed Containers and Methods of Making and Filling Same,” which, in turn, claims benefit of similarly titled U.S. Provisional Patent Application No. 60/408,086, filed Sep. 3, 2002, each of which is hereby expressly incorporated by reference in its entirety as part of the present disclosure.
- the closure 14 comprises a first closure 22 and a second closure 24 .
- the first and second closures 22 , 24 are angularly moveable with respect to one another.
- the first and second closures are coupled via a living hinge 26 .
- the second closure may be connected to either of the first closure or body via any of numerous connections that are currently known or that later become known to allow movement of at least one of the closures relative to the other.
- first and second closures 22 , 24 need not be connected in the open position, but rather may be connected only in the closed position when the second closure overlies and sealingly engages a penetration aperture in the first closure. Where the first and second closures 22 , 24 are connected in the open position, they may be molded in one piece, as shown.
- Both the first and second closures 22 , 24 include first and second substantially centered recesses 28 , 30 respectively, axially extending from the top surfaces of the closures for sealingly receiving therein first and second penetrable septums 32 , 34 , respectively.
- the penetrable septums may be made of any material that is penetrable by a needle, injection or filling member.
- the material may be a needle-penetrable elastomeric, rubber or rubber-like material that is sufficiently elastic to be penetrated by a needle.
- the septum materials also are sufficiently elastic to substantially close a resulting penetration aperture after removal of a needle or like injection member therefrom. It should be noted, though, as described in the inventor's below-referenced U.S.
- the aperture or hole may sufficiently close to prevent leaking or passage of liquid through the septum, it may not close sufficiently to prevent passage of gases, e.g. air, or other contaminants, e.g., microbial forms, especially over time.
- the material is sufficiently elastic to thereby hermetically reseal itself. In embodiments where the material is under internal compression, the compression stresses can assist in closing/resealing the hole.
- the first and second penetrable septums 32 , 34 are co-molded with the first and second closure portions 22 , 24 , respectively.
- first and second penetrable septums 32 , 34 are over-molded with the first and second closure portions 22 , 24 , respectively, e.g., at the same time, as shown in FIGS. 2A and 2B .
- the second closure portion 24 can then be mounted onto the body 12 as shown in FIGS. 2C and 2D .
- the penetrable septums may be mounted within the first and second recesses in any of numerous ways configured to sealingly mount the septums therein, and the container may be assembled in a different order.
- the closure 14 may be mounted on the body 12 , and then the septums 32 , 34 joined with the first and second closure portions 22 , 24 .
- the first closure 22 includes an annular sidewall 36 axially extending from the perimeter of the top surface thereof, defining an axially extending annular channel 38 between the annular sidewall 36 and the annular wall of the annular recess 28 .
- the annular channel 38 receives therein a portion of the top end of the cylindrical sidewall 16 of the body 12 , when the first closure is mounted atop the body.
- the top end of the cylindrical sidewall 16 of the body defines an annular tapered protuberance 40 .
- the tapered protuberance 40 defines a tapered surface 42 on an external side of the sidewall 16 .
- the body sidewall 16 defines a laterally extending annular recess 44 , extending inwardly from the exterior of the sidewall.
- the bottom end of the annular sidewall 36 of the first closure defines a corresponding annular tapered protuberance 46 .
- the tapered protuberance 46 defines a tapered surface 48 on the interior of the sidewall 36 .
- the sealed empty chamber may be sterilized with a fluid sterilant prior to filling, as disclosed in U.S. patent application Ser. No. 13/529,951, filed Jun. 21, 2012, entitled “Fluid Sterilant Injection Sterilization Device and Method,” which, in turn, claims the benefit of U.S. Provisional Patent Application No. 61/499,626, filed Jun. 21, 2011, entitled “Nitric Oxide Injection Sterilization Device and Method,” each of which is hereby expressly incorporated by reference in its entirety as part of the present disclosure as if fully set forth herein.
- the second closure 24 is moveable between a first position (shown in FIGS. 2D , 3 A, 9 A and 10 A), spaced away from the first closure 22 , and a second position (shown in FIG. 4 ), where the second closure 24 mounts atop the first closure 22 .
- the first position the second penetrable septum 34 is not sealingly engaging the first penetrable septum 32 .
- the second penetrable septum 34 sealingly overlies the penetrable portion of the first penetrable septum 32 , thus creating a mechanical seal, as explained further below.
- the second closure 24 includes an annular sidewall 52 axially extending from the perimeter of the top surface thereof, and is configured to fittingly receive the first closure 24 therein when in the second position.
- the bottom end of the second closure annular sidewall 52 defines an annular tapered protuberance 54 .
- the tapered protuberance 54 defines a tapered surface 56 on the internal side of the sidewall 52 .
- the second axially-extending recess 30 of the second closure 24 When in the second position, the second axially-extending recess 30 of the second closure 24 , containing the second penetrable septum 34 therein, sealingly fits within the first penetrable septum 32 , thereby sealingly engaging the second penetrable septum atop the penetrable portion of the first penetrable septum.
- the first penetrable septum 32 is approximately dome or convex shaped on a side thereof opposite the chamber 11 .
- the second penetrable septum 34 is correspondingly approximately dome or convex shaped as well on a side thereof substantially opposite the first penetrable septum 32 , in order to sealingly mate with the contour of the first penetrable septum.
- a filling device penetrates the first penetrable septum 32 , when the second closure 24 is in the second or open position.
- An exemplary needle is disclosed in U.S. patent application Ser. No. 13/450,306, filed Apr. 18, 2012, entitled “Needle with Closure and Method,” which, in turn, claims benefit of U.S. Provisional Patent Application No. 61/476,523, filed Apr. 18, 2011, entitled “Filling Needle and Method,” each of which is hereby expressly incorporated by reference in its entirety as part of the present disclosure as if fully set forth herein.
- a filling device 60 is utilized to fill the device 10 .
- the filling device 60 comprises a hollow filling member 62 , a tip 64 formed at one end of the filling member, two ports 66 in fluid communication with the interior of the hollow filling member 62 , a first or relatively rigid closure 68 , and a second closure or relatively flexible annular shell 70 .
- the filling member 62 includes a boss 72 at approximately a middle portion thereof. As can be seen, the boss 72 defines an annularly and axially extending recess therein for receiving a proximal portion of the closure 68 and a biasing member 74 that engages and biases the closure, as described further below.
- the two ports 66 are diametrically opposed relative to each other; however, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the filling device may define any number of ports that may define any of numerous different configurations and locations.
- the closure 68 and/or the filling member 62 is movable between (i) a first position wherein the closure closes the ports 66 , as shown typically in FIG. 6A , and (ii) a second position opening the ports 66 , as shown typically in FIG. 6B .
- the closure 68 forms a substantially fluid-tight seal between the ports 66 and ambient atmosphere.
- the closure 68 is biased via the biasing member 74 in the direction from the second or open position toward the first or closed position to normally close the ports 66 .
- the biasing member 74 is a coil spring.
- the closure may be biased in any of numerous different ways that are currently known or that later become known, using biasing members other than springs. Further, if a spring is used, any of numerous different springs or combinations of springs may be used.
- the closure 68 is a “shutter” closure that slides axially over the filling member 62 between the normally closed and open positions.
- the closure may take any of numerous different configurations that are currently known, or that later become known, for performing the function of the closure as described herein.
- the closure 68 extends both annularly and axially about the filling member 62 and is slidably mounted on the filling member.
- the closure 68 includes an annular flange 76 adjacent to a proximal end thereof that is engageable with the biasing member 74 for biasing the closure in the direction from the second or open position toward the first or closed position.
- An opposing distal end 78 of the closure 68 is engageable with an annular stop surface 80 of the filling member tip 64 to stop the closure in the first or closed position.
- the distal end 78 of the closure 68 tapers inwardly to define a perimeter substantially flush with the perimeter of the stop surface 80 and adjacent portion of the filling member tip 64 . As shown in FIGS.
- the closure 68 ( FIG. 8B ) and/or the filling member tip 64 ( FIG. 8A ) includes an annular seal 82 , between the distal end 78 of the closure and the tip 64 of the filling member, to further ensure the formation of a fluid-tight seal at the junction of the closure and filling member.
- the seal 82 is o-ring shaped and is over-molded to the filling member tip 64 .
- the O-ring shaped seal 82 is over-molded to the distal tip of the closure 68 .
- the seal may or may not be integral with the closure and may take the form of any of numerous different types of seals or sealing members that are currently known or that later become known, to facilitate the formation of fluid-tight seal at the juncture of the closure and filling member.
- the proximal end of the closure 68 is slidably received within the annular recess of the boss 72 of the filling member 62 , and the biasing member 74 is located between the rear wall 84 of the boss 72 and the annular flange 76 .
- the flexible closure or shell 70 sealingly encloses the boss 72 of the filling member 62 .
- the flexible shell forms a bellows to allow the shell to axially expand when moving into the first or closed position ( FIG. 6A ) and to axially contract when moving into the second or open position ( FIG. 6B ).
- the flexible shell may take any of numerous different configurations that are currently known, or that later become known, for performing the function of the shell as described herein.
- the flexible shell sealingly engages an outwardly projecting annular flange 86 of the boss 72 near the proximal end thereof, and sealingly engages an annular flange 88 of the closure 68 at the distal end thereof.
- the closure annular flange 88 projects radially outwardly from an approximate mid-portion of the closure 68 .
- the portion of the flexible shell 70 proximally adjacent to the boss annular flange 86 includes an integrally the boss 72 .
- the boss 72 includes corresponding venting holes 92 located adjacent to the rear wall 84 that are normally sealed by the valve 90 .
- the venting holes 92 are in fluid communication with the interior recess of the boss 72 .
- the interior of the boss 72 is in fluid communication with one or more annularly and axially extending channels formed between the closure 68 and filling member 62 which, as shown in FIGS. 7C and 10C , are in fluid communication with a chamber to be filled when the closure is located in the second or open position.
- the biasing member 74 is compressed upon movement of the closure from the first position to the second position, sufficient fluid pressure within the boss 72 (i.e., at or above the venting valve opening pressure) will cause the venting valve 90 to move radially outwardly relative to the holes 92 to thereby allow one-way venting of any such air or other gases into the ambient atmosphere.
- any air or other gases e.g., nitrogen
- the valve 90 resiliently returns to its sealing position overlying and engaging the holes 92 .
- the venting valve 90 allows one-way venting of air or other gases through the venting holes 92 , and into the shell 72 when a vacuum is present therein.
- the venting valve may take the form of any of numerous integral or non-integral valves, that are currently known or that later becomes known, capable of performing the function of the venting valve as described herein.
- the filling device tip 64 is defined by a non-coring, conically-pointed tip; however, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the filling device tip may define any of numerous other tip configurations that are currently known, or that later become known, such as a trocar tip.
- the spring force of the biasing member 74 is sufficient to allow the filling device 60 to penetrate a septum of an opposing device while maintaining the closure 68 in the closed position during penetration of the closure through the septum and until the annular flange 88 of the closure engages an exterior surface of the septum (or other exterior or stop surface of the device to be filled) to cause relative movement of the closure and filling member against the bias of the biasing member 74 from the normally closed position to the open position and, in turn, expose the sterile filling device ports 66 , 66 within the sterile device chamber.
- a filling line attachment fitting 94 is formed on a proximal end of the filling member 62 .
- the attachment fitting 94 is a barbed fitting for attachment to a filling line (not shown).
- any of numerous different types of fittings, connections or connectors that are currently known, or that later become known, equally may be employed for connecting the filling device to a filling or other type of line or conduit.
- the proximal end of the filling device may define a male or a female connector for aseptically or sterile connecting to the other of the male or female connector attached to a filling line, as disclosed in U.S. patent application Ser. No.
- the filling device 60 may be used to aseptically or sterile fill fluids through the first penetrable septum 32 and into the chamber 11 of the device 10 .
- the closure 68 prior to penetrating the first septum 32 , and when the filling device tip 64 is exposed to the ambient atmosphere, the closure 68 is in the closed position sealing the ports 66 with respect to ambient atmosphere to thereby maintain the sterility of the ports and of the interior of the filling device.
- FIGS. 7B and 10B upon penetrating the first septum 32 , the closure 68 remains interposed between the ports 66 and the first penetrable septum 32 to substantially prevent contact between the ports and the septum.
- the bottom surface of the annular flange 88 of the closure engages the top surface of the first closure 22 and prevents further movement of the shutter closure 68 relative to the first closure 22 .
- Further penetration of the filling device 60 into the chamber of the device 10 causes the filling member 62 and filling device tip 64 to slide relative to the shutter closure 68 against the bias of the biasing member 74 to, in turn, move the ports 66 to the open position.
- the biasing member 74 is compressed with further movement of the shutter closure from the closed position to the open position, any fluid pressure within the shell 72 above of the venting valve opening pressure is allow to flow through the venting valve 90 into the ambient atmosphere. In the open position of FIGS.
- the fluid or other substance within the filling device is permitted to flow through the open ports 66 and into the chamber 11 .
- Any fluid within the chamber 11 that is displaced by the substance flowing into the chamber is allowed to vent through the channels formed between the shutter enclosure 68 and filling device 62 and, in turn, through the venting valve 90 . Since the sterile ports 66 are never exposed to the ambient atmosphere throughout the filling process, the ports, interior of the filling device, and fluid flowing therethrough, are not contaminated and/or are maintained aseptic or sterile as the fluid is injected or otherwise filled into the chamber 11 .
- the first septum 32 comprises a lower, i.e., base, layer having a relatively high durometer and an upper layer having a relatively lower durometer.
- the upper layer is not bondable with the lower layer and is over-molded thereon.
- the first septum 32 wipes the tip 64 of the filling member 62 and the shutter closure 68 of contaminants thereon during engagement and penetration of the septum by the tip to, in turn, prevent the tip and/or shutter closure from introducing such contaminants into the sterile interior of the chamber 11 and thereby maintain the chamber and any substance therein aseptic or sterile.
- the effectiveness of such wiping during penetration of the septum is dependent, in part, upon the pressure applied by the septum onto the tip of the filling member as it penetrates through, as well as the coefficient of friction therebetween.
- the first septum 32 is approximately dome or convex shaped.
- the present inventor has determined that the dome or convex shape increases the internally directed pressure applied by the septum 32 onto the tip 64 from the beginning of piercing, as the tip inverts the convexity of the septum in order to penetrate therethrough.
- the thickness of the septum (increasing the length of the wiping effect) and durometer thereof also affect the pressure applied by the septum onto the tip.
- the durometer of the septum 32 , or the layers thereof is within the range of about 5 Shore A to about 65 Shore A, such as, for example, within the range of about 20 Shore A to about 50 Shore A.
- the durometer of the septum 32 is within the range of about 25 Shore A to about 45 Shore A. In some such embodiments, the septum thickness is within the range of about 1 ⁇ 2 to about two times the largest diameter of the tip 64 of the filling member 62 .
- the material of the filling member 62 and the septum 32 also may be selected to enhance the wiping effect.
- the present inventor has determined that the use of a plastic filling member provides the appropriate friction coefficient range to enhance the wiping effect.
- the plastic material is also easier to mold, and thus easier to manufacture and assemble.
- a septum made of a homogeneous elastic material defining a substantially homogeneous density will enhance the wiping effect.
- the filling member 62 is formed of plastic, such as any of numerous different thermoplastics, including the liquid crystal polymers (LCP) that are highly crystalline, thermotropic (melt-orienting) thermoplastics and sold under the trademark VectraTM by Celanese Corporation, or graphene.
- LCP liquid crystal polymers
- the first septum 32 is made of silicone. In other embodiments, the first septum 32 is made of a vulcanized rubber or a thermoplastic elastomer. However, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the filling member and septum may be made of any of numerous different materials that are currently known, or that later become known, to perform the functions of the filling member and septum disclosed herein.
- the configuration of the filling member itself also enhances the effectiveness of the wiping effect.
- the included angle of the tip 64 of the filling member affects the progressively increasing thickness of the tip, and the diameter of the filling device, i.e., the outer diameter of the shutter closure. As the filling member 62 penetrates through the first septum 32 , the internal pressure applied by the septum onto the tip 64 , and thereafter onto a portion of the rigid closure increases proportionally to the progressively increasing tip diameter, resulting from the included angle of the tip.
- the included angle of the tip of the piercing member is within the range of about 20 degrees to about 40 degrees, and such as about 30 degrees.
- the present inventor has determined that the wiping effect on a filling member tip by a septum having properties as aforementioned may achieve at least approximately a 3 log reduction in bio-burden when filling member tip penetrates a septum while immersed in a broth, which is about the reduction achieved by known UV pulse (5 second) sterilization techniques, and up to approximately a 6 log reduction in bio-burden. Therefore, one advantage of the present invention is that the wiping of the filling device tip allows substantially sterile filling of fluids within a non-aseptic, non-sterile or relatively low sterility assurance level (“SAL”) environment (e.g., about 6 log bio-burden or lower).
- SAL sterility assurance level
- the filling device 60 may sterile fill a substance into the device 10 without the need to decontaminate the septum of the device or the tip of the filling device prior to filling.
- the combination of the maintained sterility of the ports 66 and interior of the filling device 60 , as well as the wiping effect provided by the first septum 32 effectively sterilize the tip 64 of the filling member 62 upon penetration of the filling member through the septum. Therefore sterile filling is achieved without the need to take conventional sterilization steps, such as the application of UV radiation, for example.
- an unclassified environment e.g., about log 6 or higher
- an unclassified environment is an environment having a number and size of particles per volume greater than 100,000 particles per cubic meter of 0.5 ⁇ m or larger in diameter, i.e., a class 100,000 environment.
- the filling device 60 is withdrawn from the first septum 32 .
- the biasing member 74 biases the rigid closure 68 downwardly or in the direction of the septum 32 . Therefore, as the filling member 62 is withdrawn, it is moved axially relative to the shutter closure 68 to, in turn, move the ports 66 into the closed position behind the closure.
- the shutter closure 68 is configured to substantially prevent contact between the filling device eyes or ports 66 , and as can be seen, the sliding shutter or closure is closed over the filling device eyes or ports prior to their passage through the septum and/or withdrawal therefrom.
- the closure 68 sealingly closes the ports 66 and prevents contamination of the ports or interior of the filling device.
- the first septum 32 is engineered in a manner known to those of ordinary skill in the pertinent art to self-close and thereby ensure that the head loss left by the residual filling device injection aperture 96 after the tip of the filling device is withdrawn substantially prevents fluid ingress therethrough. Thereafter, as shown in FIG. 4 , the second closure portion 24 is moved from the first position, and snaps into the second position, and the unpenetrated second septum 34 overlies and seals the injection aperture 96 in the first septum 32 from the ambient atmosphere. This forms a filled, sealed device as shown in FIGS. 4 and 9C .
- the exterior surface of the first closure 32 and/or the interior surface of the second closure 24 may be sterilized, such as is shown in the example of FIG. 3B , in order to prevent any contaminants from being trapped between the first and second septums 32 and 34 , respectively, after closure of the second closure to the first closure.
- Sterilization of these surfaces may be performed in any of numerous different ways that are currently known, or that later become known, including without limitation, by the application of radiation thereto, such as e-beam, laser or UV radiation, by the application of a fluid sterilant, such as vaporized hydrogen peroxide (“VHP”) or nitric oxide (“NO”), or by heated gas.
- VHP vaporized hydrogen peroxide
- NO nitric oxide
- sterilization may be achieved in accordance with the teachings of any of the following patents and patent applications, each of which is hereby expressly incorporated by reference in its entirety as part of the present disclosure: U.S. patent application Ser. No. 08/424,932, filed Apr. 19, 1995, entitled “Process for Filling a Sealed Receptacle under Aseptic Conditions,” issued as U.S. Pat. No. 5,641,004; U.S. patent application Ser. No. 09/781,846, filed Feb. 12, 2001, entitled “Medicament Vial Having a Heat-Sealable Cap, and Apparatus and Method for Filling Vial,” issued as U.S. Pat. No. 6,604,561, which, in turn, claims benefit of U.S.
- a further closure may be applied over the second closure 24 and/or second septum 34 , such as an adhesive-backed foil layer that overlies the second septum 24 and is adhesively attached to the second septum or second closure, to provide an additional barrier such as to prevent moisture-vapor transmission (“MVT”).
- MVT moisture-vapor transmission
- a syringe needle or like withdrawal device may be pierced through the first and second septums 32 , 34 and placed into fluid communication with the interior chamber 11 and the fluid or other substance therein to withdraw the fluid or other substance from the chamber and into the syringe to, for example, inject the withdrawn substance into a person.
- the first and second septums may be pierced one or more times as desired to withdraw substance from the chamber 11 until the chamber is empty as shown in FIG. 9E .
- the second closure is initially a separate piece and is not connected to the first closure. After the first closure is pierced and the device is filled with a substance, the second closure is then fixedly secured, such as by a snap fit as described above, to the first closure to sealingly engage the first and second septums, and seal the resulting penetration aperture in the first septum.
- the second closure can be pre-sterilized prior to assembly, or can be surface sterilized as described above prior to assembly to the first closure.
- the second closure can be automatically assembled to the first closure with any of numerous different assembly devices that are currently known, or that later become known, such as a pick and place robotic assembly device, or other suitable fixture that can automatically assemble the second closure to the first closure.
- a closure assembly station can be located downstream of the needle penetration and filling station to assemble the second closure to the first closure upon or following withdrawal of the filling needle from the first closure.
- FIGS. 11-12D another device is indicated generally by the reference numeral 110 .
- the device 110 is substantially similar to the device 10 described above in connection with FIGS. 1-4 and 9 A- 10 B, and therefore like reference numerals preceded by the numeral “1” are used to indicate like elements.
- a primary difference of the device 110 in comparison to the device 10 is the design of the closure 114 and that the first penetrable septum 132 is not integrated into the closure 114 . Rather, the first penetrable septum 132 is separate from the closure and seats into the opening 118 of the body 112 .
- a lower portion 122 of the closure 114 sealingly clamps the first penetrable septum 132 into the body opening 118 .
- An upper portion 124 of the closure 114 defines a laterally-extending slot 124 a configured to slidably receive the second penetrable septum 134 therein, for sealing the first septum 132 after penetration thereof, as hereinafter described.
- the body 112 includes an annular, laterally-extending flange 120 spaced from the opening 118 , and a neck 113 extending upward from the periphery of the flange 120 to the opening 118 .
- the first septum 132 includes a corresponding annular, laterally-extending flange 132 a dimensioned for engagement with the flange 120 of the body 112 .
- the septum 132 also includes an annular, axially-extending portion 132 b , spaced radially inwardly relative to the flange 132 a and projecting axially downwardly therefrom.
- the portion 132 b extends toward the chamber 111 of the device and sealingly engages the interior surface of the body sidewall 116 and the flange 132 a engages the flange 120 .
- the closure 114 is mounted atop the first septum 132 , and onto the body 112 , to form a compression seal between the closure 114 , first septum 132 , and body 112 .
- the lower portion 122 of the closure 114 defines a substantially annular lateral slot 122 a therein defining a substantially annular inner sidewall 136 .
- the ceiling 122 b of slot 122 a i.e., the base of the upper portion 124 , defines a first aperture 128 extending between the lower and upper portions 122 , 124 .
- the sidewall 136 of the slot 122 a includes an annular lip 136 a extending laterally inwardly from the base end of the sidewall 136 .
- the lip 136 a is slightly smaller in diameter than the neck 113 .
- the lip 136 a is flexed slightly outwardly by the larger neck 113 during mounting so it can slide over and past the neck 113 . After the lip 136 a slides past the bottom of the neck, the lip 136 a resiliently returns to its original size and engages the bottom surface of the flange 120 of the body 112 , in a snap-fit type engagement, to hold the closure 114 in place.
- the neck 113 of the body 112 defines a slot (not shown) adapted to receive therein a corresponding tab (not shown) projecting from the interior surface of the closure 114 , such that the closure 114 only mounts onto the body 112 when the tab and slot align, in a key-and-groove type configuration. Thus, the closure 114 only mounts onto body 112 in a designated orientation relative thereto.
- the height of the slot 122 a i.e., the distance between the ceiling 122 b and the lip 136 a is approximately the same as the height of the neck 113 . However, the height of the slot 122 a is slightly less than the height of portion of the first septum 132 to be retained in the slot 122 a .
- the ceiling 122 b of the slot 122 a abuts the upper surface of the first septum 132 and compresses and/or depresses the first septum 132 into the neck 113 and, in turn, creates a compression seal between the closure 114 , the septum 132 and the body 112 .
- the first septum 132 is approximately dome or convex shaped on the upper side thereof, opposite the chamber 111 .
- an approximately central portion of the convex upper surface of the septum 132 bulges through the aperture 128 and partially into the upper portion 124 .
- the upper portion 124 of the closure 114 defines the lateral slot 124 a therein.
- slot 124 a includes the first aperture 128 in the base thereof, connecting to the slot 122 a .
- the slot 124 a defines a second aperture 130 , substantially vertically aligned with the first aperture 128 , thereby exposing the first penetrable septum 132 for filling therethrough.
- the slot 124 a also defines an opening 124 b in the sidewall thereof for receiving a disk 125 therethrough and into the slot 124 a .
- the disk 125 is shaped and configured to fit into and substantially mate with the corresponding interior shape of the slot 124 a .
- the disk 125 is dimensioned, relative to the interior dimensions of the slot 124 a , to create a dimensional interference therewith.
- the thickness of the slot 124 a (perpendicular to the lateral extent of the slot 124 a ) is slightly less than the thickness of the disk 125 , and therefore the disk 125 creates an interference fit with the slot 124 a when inserted, e.g., wedged, therein.
- the disk 125 forms a sliding, fluid-tight seal between itself and the interior surfaces of the walls of the slot 124 a when inserted therein.
- the disk 125 includes the second penetrable septum 134 . Similar to the embodiment described above, the second penetrable septum 134 can be co-molded with the disk 125 . Alternatively, the second septum 134 can be over-molded onto the disk 125 .
- the disk 125 is initially inserted into the slot 124 a in a first position, as shown in FIG. 12B .
- the disk 125 is mechanically inserted into the slot 124 a , such as, for example, via a solenoid operated arm
- the disk 125 is movable, i.e., slideable, within the slot 124 a between the first position where the disk 125 is positioned away from the first septum 132 bulging through the first aperture 128 , and a second position ( FIG. 12D ) where the disk 125 is positioned between the first and second apertures 128 , 130 , and the second septum 134 overlies the first septum 132 .
- the second septum 134 sealingly engages, i.e., overlies, the bulging portion of the first septum 132 .
- the portion of the first septum 132 bulging partially into the slot 124 a narrows the thickness of the slot 124 a at that location within the slot, corresponding to the location of the second position of the disk 125 .
- the second septum 134 compresses against the bulging portion of the first septum 134 , and, in turn, forms a mechanical compression seal therewith.
- the compression force on the disk 125 and second septum 134 assists in maintaining the disk in the second position, e.g., by friction or wedging, during storage and subsequent use.
- the assembled device 110 i.e., the body 112 , closure 114 , disk 125 , first and second septums 132 , 134 and/or any component parts, can be sterilized with the disk 125 in the first position, as shown in FIG. 12B .
- Sterilization of the device 100 may be performed in any of numerous different ways that are currently known, or that later become known, including without limitation, by the application of radiation thereto, such as e-beam, laser or UV radiation, by the application of a fluid sterilant, such as vaporized hydrogen peroxide (“VHP”) or nitric oxide (“NO”), or by heated gas in accordance with the teachings of any of the patents and patent applications incorporated by reference above.
- VHP vaporized hydrogen peroxide
- NO nitric oxide
- a filling device such as the filling device 60 disclosed above or in any of the patents and patent applications incorporated by reference above, can be advanced through the second aperture 130 to penetrate the first penetrable septum 132 and aseptically or sterile fill fluid into the sterile chamber 111 of the device 110 ( FIG. 12C ).
- the first septum 132 wipes the tip of the filling member of contaminants thereon during engagement and penetration of the septum 132 by the tip, to, in turn, prevent the tip from introducing such contaminants into the sterile interior of the chamber 111 , thereby maintaining the chamber 111 and any substance therein aseptic or sterile.
- the filling device is withdrawn from the first septum 132 .
- the first septum 132 can be engineered in a manner known to those of ordinary skill in the pertinent art to self-close and thereby ensure that the head loss left by the residual filling device injection aperture 196 after the tip of the filling device is withdrawn substantially prevents fluid ingress therethrough.
- the disk 125 is slidably pressed from the first position into the second position ( FIG. 12D ), such that the unpenetrated second septum 134 overlies and seals the injection aperture 196 in the first septum 132 from the ambient atmosphere in a similar manner as described in the above embodiment.
- the disk 125 surrounding the second septum 134 remains in sealing engagement with the interior surfaces of the slot 124 a .
- the bulging surface of the first closure 132 can be re-sterilized in order to prevent any contaminants from being trapped between the first and second septums 132 , 134 .
- the openings of the filled device 110 can be sealed, such as, for example, via shrink wrap, to provide an additional barrier.
- a tamper-proof layer 115 can be applied over the closure 114 after filling.
- the tamper-proof layer 115 is an adhesive-backed foil layer adhesively attached to the closure 114 , overlying the second aperture 130 and the second septum 134 .
- the foil layer 115 also indicates whether the device 110 has been tampered with after filling thereof and prior to withdrawing the filled fluid therefrom.
- a withdrawal device When ready for use, a withdrawal device may penetrate or pierce through the first and second septums 132 , 134 to withdraw fluid from the chamber 111 .
- the second septum 134 is off-center within the disk 125 , so that a withdrawal device penetrating through the second septum 134 , e.g., through the center thereof, can penetrate through the first septum 132 at a previously unpenetrated location and not through the injection aperture 196 .
- FIGS. 13-16 another device is indicated generally by the reference numeral 210 .
- the device 210 is substantially similar to the device 110 described above in connection with FIGS. 11-12D , and therefore like reference numerals preceded by the numeral “2” are used to indicate like elements.
- a primary difference of the device 210 in comparison to the device 110 is the second penetrable septum 234 is large enough to sealingly cover the first penetrable septum 232 in both the first and the second positions, as hereinafter described.
- the second penetrable septum 234 within the disk 225 , includes a first portion 234 a and a second portion 234 b .
- the first portion 234 a of the second septum 234 is positioned between the first and second apertures 228 , 230 , and sealingly overlies the bulging portion of the first septum 232 in similar manner as described above in the embodiment of device 110 .
- the assembled device 210 ( FIG. 14 ), with the disk 225 in the first position, can be sterilized prior to filling. Similar to the embodiment of device 110 above, the disk 225 creates a dimensional interference with the slot 224 a , thereby creating a sliding seal between the disk 225 and the slot 224 a . The seal therebetween maintains the sterility of the second portion 234 b of the second septum 234 in the first position, i.e., during filling. Thereafter, as shown in FIG.
- a filling device such as, for example, the filling device 60
- the filling device 60 can be advanced through the second aperture 230 , and, in turn, penetrate both the first portion 234 a of the second septum 234 and the first septum 232 to aseptically or sterile fill fluid into the sterile chamber 211 of the device 210 .
- the first portion 234 a of the second septum 234 and the first septum 232 wipe the tip of the filling device of contaminants thereon during engagement and penetration of the septums thereby to, in turn, prevent the filling device from introducing such contaminants into the sterile interior of the chamber 211 and thereby maintain the chamber and any substance therein aseptic or sterile.
- the disk 225 is slidably pressed from the first position ( FIG. 15 ) into the second position ( FIG. 16 ).
- the first portion 234 a of the second septum 234 is sealed off from the remainder of the device 210 when the disk 225 is moved from the first position into the second position.
- the first portion 234 a of the septum 234 defines a substantially concave upper surface.
- the portions of the disk 225 and the second septum 234 surrounding the first portion 234 a of the second septum and sealingly engaging the interior surfaces of the upper and lower walls of the slot 224 a trap, i.e., seal off, any contamination residing on the first portion 234 a in the pocket between the concave surface and the upper wall of the slot 224 a , e.g., from contact with and wiping of the tip of the filling member 60 .
- the sterile, unpenetrated second portion 234 b of the second septum 234 is positioned between the first and second apertures 228 , 230 , and sealingly overlies the bulging portion of the first septum 232 .
- the fluid within the chamber 211 is hermetically sealed.
- the first septum 232 is covered by the second septum 234 before, during and after penetration thereof, and thus the upper surface of the first septum 232 is never exposed to the ambient atmosphere and remains substantially sterile, particularly in embodiments where the second septum 234 wipes the injection member 60 . Therefore, no re-sterilization is required after filling.
- a needle or like withdrawal device can thereafter penetrate the second portion 234 b of the second septum 234 and the first septum 232 to withdraw liquid from the chamber 211 , in a similar manner as described above.
- FIGS. 17-18 another device is indicated generally by the reference numeral 310 .
- the device 310 is substantially similar to the devices 110 , 210 described above in connection with FIGS. 11-16 , and therefore like reference numerals preceded by the numeral “3” are used to indicate like elements.
- a primary difference of the device 310 in comparison to the devices 110 , 210 is that the device 310 includes a single penetrable septum 334 .
- the septum 334 defines a first portion 334 a for filling therethrough when the disk 325 is located in the first position and a second portion 334 b for sealing the contents of the device 310 and withdrawing substance therefrom when the disk 325 is located in the second position, as hereinafter described.
- the device 310 comprises a body 312 , a closure 314 and a disk 325 including the penetrable septum 334 .
- the closure 314 is sealingly mounted atop the upper end of the body 312 .
- the upper rim of the body 312 defines an annular spike 312 a that sealingly engages the base surface of the closure 314 .
- the closure 314 includes an annular, axially-extending projection 314 a , spaced radially inwardly relative to the perimeter of the closure 314 and projecting axially downwardly from the base of the closure 314 .
- the projection 314 a is dimensioned to sealingly engage a portion of the body sidewall 316 adjacent the opening 318 thereof.
- the diameter of the projection 314 a is dimensioned, relative to the outer diameter of the body 312 , to create a dimensional interference therewith, thereby creating a fluid-tight interference fit therebetween.
- the closure 314 defines a lateral slot 324 a .
- the slot 324 a defines a first aperture 328 in the base end thereof, connecting the slot 324 a in fluid communication with the chamber 311 of the device 310 .
- the slot 324 a also defines a second aperture 330 in the upper end thereof substantially vertically aligned with the first aperture 328 .
- the slot 324 a has an opening 324 b in the sidewall thereof for receiving the disk 325 , with the penetrable septum 334 , therethrough.
- the disk 325 is shaped to mate with the corresponding interior shape of the slot 324 a and is dimensioned to create a dimensional interference therewith.
- the disk 325 forms a sliding, fluid-tight seal between itself and the interior surfaces of the slot 324 a.
- the disk 325 is initially inserted into the slot 324 a into the first position, as shown in FIG. 18 .
- the first portion 334 a of the penetrable septum 334 is positioned between the first and second apertures 328 , 330 and forms a sealed, assembled device.
- the sealed, assembled device 310 with the disk 325 in the first position, can be sterilized prior to filling.
- the seal between the disk 325 and the slot 324 a maintains the sterility of the second portion 324 b of the septum 334 while in the first position, e.g., during filling.
- a filling device such as, for example, the filling device 60
- the septum 334 wipes the tip of the filling device of contaminants thereon during engagement and penetration of the septum by the filling device to, in turn, prevent the filling device from introducing such contaminants into the sterile interior of the chamber 311 .
- the disk 325 is slidingly pressed from the first position into the second position ( FIG. 20 ), such that the sterile, unpenetrated second portion 334 b is positioned between the first and second apertures 328 , 330 . Because of the seal between the disk 325 and the slot 324 a , and because the second portion 334 b is unpenetrated, the fluid within the sterile chamber 311 is hermetically sealed. The first portion 334 a of the septum 334 is also sealed off from the remainder of the device 310 when the disk 325 is moved from the first position into the second position.
- the first portion 334 a of the septum 334 defines substantially concave upper and lower surfaces, which function similar to the concave surface of the septum 234 of device 210 . Accordingly, in the second position, the portions of the disk 325 and the septum 334 surrounding the first portion 334 a of the septum and sealingly engaging the interior surfaces of the slot 324 a , trap, i.e., seal off, any contamination, such as liquid residue, residing on the first portion 334 a in the pockets between the concave surfaces of the first portion 334 a of the septum 334 and the respective upper and lowers walls of the slot 324 a.
- FIGS. 21-23 another device is indicated generally by the reference numeral 410 .
- the device 410 is substantially similar to the devices 10 , 110 , 210 , 310 described above in connection with FIGS. 1-20 , and therefore like reference numerals preceded by the numeral “4” are used to indicate like elements.
- a primary difference of the device 410 in comparison to the devices 10 , 110 , 210 , 310 is that the device 410 includes a closure 414 that is rotatable relative to the body 412 to selectively expose a filling septum 432 and a withdrawal septum 434 , as hereinafter described.
- the device 410 includes a body 412 , a septum assembly 433 , and a closure 414 .
- the septum assembly 433 comprises a penetrable bottom septum layer 433 a and an overlay layer 433 b .
- the overlay layer 433 b defines two apertures, receiving therein corresponding projections of the septum layer 433 a to define a penetrable filling septum 432 and a separate penetrable withdrawal septum 434 .
- the septum layer 433 a and thus the filling and withdrawal septums 432 , 434 can be made of an elastomeric material, such as, for example, silicone, vulcanized rubber or a thermoplastic elastomer, as described above.
- the septum assembly 433 is shaped and dimensioned to mount into the neck 413 and engage the flange 420 of the body 412 .
- the septum assembly includes diametrically opposed tabs 433 c fittingly engageable with corresponding diametrically opposed slots 413 a in the neck 413 of the body 412 .
- the septum assembly 433 is not rotatable within the neck 413 .
- the septum assembly and neck may have fewer (e.g., one) or more two tabs and slots, respectively, which in any case need not be diametrically opposed, or no tabs/slots at all.
- the closure 414 mounts atop the body 412 and forms a compression seal between the closure 414 , the septum assembly 433 , and the body 412 in similar manner as described above with respect to the embodiment of device 110 .
- the closure 414 includes an aperture 428 in the upper surface thereof and is assembled onto the body 412 in a first position or orientation relative to the septum assembly such that the aperture 428 is positioned above or over the filling septum 432 , as shown in FIG. 22 . In the first position with the filling septum 432 exposed, the seal between the closure 414 and the remainder of the septum assembly 433 maintains the sterility of the remainder of the assembly 433 .
- the closure 414 is rotatable about the neck 413 from the first position into a second position, to, in turn, position the aperture 428 above withdrawal septum 434 , as shown in FIG. 23 . Due to the above-discussed compression seal, the seals between the body 412 , septum assembly 433 , and closure 414 are maintained during rotation. Once rotated into the second position, a tab 433 d projecting upwardly from the overlay layer 433 b engages a corresponding slot or recess in the upper end of the closure 414 (not shown), thereby substantially preventing reverse rotation of the closure 414 from the second position back toward the first position (or at least prevent inadvertent rotation).
- the assembled device 410 can be sterilized in like manner prior to filling. Thereafter, with the closure 414 in the first position, a filling device, such as the filling device 60 disclosed above or in any of the patents and patent applications incorporated by reference above, can be advanced through the aperture 428 to penetrate the filling septum 432 and aseptically or sterile fill fluid into the sterile chamber 411 of the device 410 .
- a filling device such as the filling device 60 disclosed above or in any of the patents and patent applications incorporated by reference above, can be advanced through the aperture 428 to penetrate the filling septum 432 and aseptically or sterile fill fluid into the sterile chamber 411 of the device 410 .
- the filling septum 432 wipes the tip of the filling member of contaminants thereon during engagement and penetration of the septum 432 by the tip, to, in turn, prevent the tip from introducing such contaminants into the sterile interior of the chamber 411 , thereby maintaining the chamber 411 and any substance therein aseptic or sterile.
- the filling device is withdrawn from the filling septum 432 .
- the closure 414 is then rotated into the second position, covering and sealing off the penetrated filling septum 432 , thereby hermetically sealing the fluid within the sterile chamber 411 .
- the unpenetrated, sterile withdrawal septum 434 is exposed.
- a withdrawal device may thereafter penetrate through the septum 434 to withdraw the fluid from the chamber 411 .
- the components of the container or other device and the filling device may be made of any of numerous different materials that are currently known, or that later become known, for performing the function(s) of each such component.
- the components of the container or other device and filling device may take any of numerous different shapes and/or configurations.
- the filling device may be used to inject any of numerous different types of fluids or other substances into the container or other device for any of numerous different applications, including, for example, medicaments, pharmaceuticals, vaccines, liquid nutrition products, supplements, and numerous other products that are currently known, or that later become known. Accordingly, this detailed description of embodiments is to be taken in an illustrative, as opposed to a limiting sense.
Abstract
Description
- This patent application claims benefit under 35 U.S.C. §119 to similarly-titled U.S. Provisional Patent Application Nos. 61/659,382, filed Jun. 13, 2012, and 61/799,744, filed Mar. 15, 2013, both of which are hereby incorporated by reference in their entirety as part of the present disclosure.
- The present invention relates to a device, such as a container, vial or dispenser, with a septum that is penetrable for filling a chamber with a substance therethrough, a closure that closes the penetrated septum and is itself penetrable for accessing the substance filled into the chamber, and a filling device for filling the chamber through the septum, and related methods.
- A typical previously-known vial having a penetrable septum for filling therethrough leaves a residual injection aperture in the septum after a filling needle penetrates and withdraws therefrom. Hermetically resealing the penetrated septum requires utilizing an external source such as radiation or chemicals. While such methods are effective, one drawback is that radiation or chemical resealing requires relatively expensive parts in a filling assembly line.
- A typical previously-known filling needle includes a hollow stainless steel shaft, a non-coring, conically-pointed tip fixedly secured to the distal end of the shaft, and diametrically opposed fluid ports proximal to the tip and in fluid communication between the interior of the shaft and the ambient environment. One drawback encountered with previously-known filling needles is that the interior of the needle, and any fluid contained therein or passing therethrough, can be exposed to the ambient environment via the open fluid ports. In connection with known filling machines, regulatory agencies require control of the filling needle environment in order to protect against exposure of a sterile product to the environment and the resulting contamination of the product that might occur. However, typical controlled environments, such as a class 100 (ISO-5) controlled environment, are not truly sterile. Although the likelihood of contamination in such reduced-contaminant environments may be relatively low, just one colony of contaminants can develop into a container full of germs over its shelf-life. This risk is exacerbated when filling traditional open containers that are thereafter sealed in an assembly machine. No such previously-known assembly machine, such as, for example, a typical machine closing 40,000 containers per hour, can fully prevent entrance of viables and non-viables into the containers. Another drawback of the needle opening is the build-up of product around the opening, or even dripping.
- It is an object of the present invention to overcome one or more of the above-described drawbacks and/or disadvantages of the prior art.
- In accordance with a first aspect, a device comprises a sealed chamber; a first penetrable septum in fluid communication with the chamber that is penetrable by a first needle or like injection member to fill the first chamber with a substance therethrough; and a second penetrable septum. The second penetrable septum is movable between first and second positions. In the first position, at least a portion of the second septum is spaced away from the first septum to allow the needle or like injection member to penetrate the first septum and aseptically or sterile fill the chamber with a substance therethrough. In the second position, said at least a portion of the second septum overlies and mechanically seals a resulting injection aperture in the first septum after withdrawal of the first needle or like injection member therefrom, and is penetrable by a second needle to penetrate the first and second septums and withdraw a filled substance from the chamber.
- In some embodiments, the device further comprises a body defining the chamber and a first closure connected to the body and forming a fluid-tight seal therebetween. The first closure includes the first penetrable septum. In some such embodiments, the device further comprises a second closure connectable to the first closure and/or body. The second closure includes the second penetrable septum. In some such embodiments, the first and/or second penetrable septums are co-molded with the first and second closures, respectively. In other embodiments, the first penetrable septum is over-molded onto the first closure, and the second penetrable septum is over-molded onto the second closure. In some such embodiments, the first and/or second penetrable septums are over-molded to the first and second closures, respectively, at the same time.
- In some embodiments, the second closure is connected to the first closure, and at least one of the first and second closures is movable relative to the other to position the second closure in the first or second positions. In some such embodiments, the device further comprises a hinge coupled between the first and second closures to allow movement of the second closure from the first open position to the second closed position. In some such embodiments, the hinge is a living hinge. In some such embodiments, the first and second closures are injection molded as one part, and the first and second penetrable septums are over-molded to the first and second closures, respectively.
- In some embodiments, the first penetrable septum is formed of an elastic material. In some such embodiments, the aperture formed in the first penetrable septum by the needle, injection or filling member substantially closes upon withdrawal of the needle, injection or filling member due to the elastic properties of the material. In yet further of such embodiments, the material is sufficiently elastic to substantially hermetically seal itself at a resulting penetration aperture after withdrawal of the first needle or like injection member therefrom. In some such embodiments, the first septum is approximately dome or convex shaped. In some such embodiments, the first septum is approximately dome or convex shaped on a side thereof substantially opposite the side of the chamber.
- In some embodiments, the second penetrable septum is approximately dome or convex shaped. In some such embodiments, the second septum is approximately dome or convex shaped on a side thereof substantially opposite or juxtaposed with respect to the upper side of the first septum in a way that the second septum and first septum provide a mechanical seal around an aperture left by a filling needle.
- In some embodiments, the first septum comprises a substantially homogeneous material, such as, for example, silicone. In some embodiments, the first septum defines a durometer within the range of about 5 Shore A to about 65 Shore A, such as within the range of about 25 Shore A to about 45 Shore A. In some embodiments, the first septum defines a thickness within the range about ½ to about twice the largest diameter of the needle or like injection member that penetrates the first septum to fill a chamber therethrough.
- In some embodiments, penetration of the first septum by the first needle or like injection member achieves at least about a 3 log reduction in bio-burden by wiping the tip of the first needle or like injection member. In some such embodiments, penetration of the first septum by the first needle or like injection member achieves at least about a 6 log reduction in bio-burden of the tip.
- In some embodiments, the first closure includes a first connecting member, the second closure includes a second connecting member, and at least one of the first and second connecting members is engageable with the other to secure the second penetrable septum in the second position. In some such embodiments, at least one of the first and second connecting members is receivable within the other to secure the second penetrable septum in the second position. In some such embodiments, the first connecting member defines a recess, and the second connector member defines a protrusion receivable within the recess to secure the second penetrable septum in the second position. In some such embodiments, the protrusion defines a chamfer or beveled surface slideable against the recess to facilitate inserting the second connecting member into the first connector member. The protrusion is engageable with an underside of the recess to secure the second connecting member to the first connecting member. In some such embodiments, the recess extends angularly about the first connecting member, and the protrusion extends angularly about the second connecting member.
- In some embodiments, the second penetrable septum is entirely spaced away from the first penetrable septum in the first position.
- In some embodiments, the device further comprises a body defining the chamber and a closure overlying the first penetrable septum and connected to the body and forming a fluid-tight seal therebetween. The second penetrable septum is slidably received in the closure. In some such embodiments, the device further comprises a disk including the second penetrable septum. In some such embodiments, the closure further defines a lateral slot therein for slidably receiving the disk therein, wherein the disk creates a dimensional interference fit with the slot, thereby creating a sliding, fluid-tight seal, therebetween.
- In some embodiments, the second septum comprises a first portion and a second portion, wherein said second portion defines said at least a portion of the second septum. In the first position, the first portion of the second septum sealingly overlies the first septum and the second portion of the second septum is spaced away from the first septum. In the second position, the second portion of the second septum sealingly overlies the first septum and the first portion of the second septum is spaced away from the first septum.
- In accordance with another aspect, a device comprises a sealed chamber; first means in fluid communication with the chamber and penetrable by a first needle or like injection member for filling the first chamber with a substance therethrough; and second means movable between a first position, wherein at least a portion of the second means is spaced away from the first means for allowing the first needle or like injection member to penetrate the first means and fill the chamber therethrough, and a second position for sealing a resulting injection aperture in the first means after withdrawal of the first needle or like injection member therefrom, and penetrable by a second needle or like injection member for penetrating the first and second means and withdrawing a filled substance from the chamber and through the second needle or like injection member.
- In some embodiments, the first means is formed of an elastic material. In some embodiments, the first means is a first penetrable septum, and the second means is a second penetrable septum.
- In accordance with another aspect, a device comprises a sealed chamber, and a penetrable septum, having a first portion and a second portion, in fluid communication with the chamber. The penetrable septum is movable between (i) a first position, wherein the first portion is in fluid communication with the chamber to allow a first needle or like injection member to penetrate therethrough, and, in turn, fill the chamber with substance, and (ii) a second position, wherein the second, unpenetrated portion, sealingly overlies the chamber after withdrawal of the first needle or like injection member therefrom. The second portion is penetrable in the second position by a second needle or like injection member to, in turn, withdraw substance from the chamber.
- In some embodiments, the device further comprises a body defining the chamber and a closure connected to the body and forming a fluid-tight seal therebetween, wherein the penetrable septum is slidably received in the closure. In some such embodiments, the device further comprises a disk including the penetrable septum. In some such embodiments, the closure further defines a lateral slot therein for slidably receiving the disk therein, wherein the disk creates a dimensional interference fit with the slot, thereby creating a sliding, fluid-tight seal, therebetween.
- In accordance with another aspect, a filling device comprises a hollow filling member. A tip is formed at one end of the filling member, at least one port is in fluid communication with the interior of the hollow filling member, and an annular shell extends radially and angularly about the filling member. A closure is coupled to the annular shell, and at least one of the closure and the filling member is movable between (i) a first position wherein the closure closes the at least one port and forms a substantially fluid-tight seal between the fluid port and ambient atmosphere to facilitate maintaining sterility of the port and interior of the filling member, and (ii) a second position opening the at least one port and allowing a flow of substance through the port.
- In some embodiments, the closure is biased in a direction from the second position toward the first position to normally close the at least one port. In some such embodiments, the filling device further comprises a biasing member biasing the closure in the direction from the second position toward the first position.
- In some embodiments, the closure is engageable with a penetrable septum to move at least one of the closure and filling member from the first position to the second position upon penetrating the septum with tip of the filling member. In some embodiments, at least one of the closure and filling member is movable from the second position to the first position during or upon withdrawing the filling member from the septum.
- In some embodiments, a distal end of the closure is engageable with a stop surface of the filling member to stop the closure in the first position and form a substantially fluid-tight seal between the closure and filling member. In some such embodiments, the filling device further comprises a sealing member located between the distal end of the closure and the stop surface and forming a substantially fluid-tight seal therebetween in the first position. In some such embodiments, the sealing member is integrally molded, such as by over molding, to the closure. In other embodiments, the sealing member is integrally molded, such as by over molding, to the stop surface.
- In some embodiments, the filling member is formed of plastic, such as any of numerous different thermoplastics, including the liquid crystal polymers (LCP) that are highly crystalline, thermotropic (melt-orienting) thermoplastics and sold under the trademark VECTRA™ by Celanese Corporation.
- In some embodiments, the annular shell forms a bellows. In some such embodiments, the annular shell includes a one-way valve in fluid communication between the hollow filling member and ambient atmosphere. In some such embodiments, the one-way valve vents out air and/or other gases from within the shell to the ambient atmosphere when the bellows is under compression.
- In accordance with another aspect, a filling device comprises first means for providing a conduit for the passage of fluid therethrough; second means formed at one end of the first means for penetrating a septum; third means in fluid communication with the conduit for passage of fluid from the conduit therethrough; and fourth means for closing the third means. At least one of the fourth means and the first means is movable between (i) a first position wherein the fourth means closes the third means and forms a substantially fluid-tight seal between the third means and ambient atmosphere to facilitate maintaining sterility of the third means and an interior of the first means, and (ii) a second position opening the third means. Some embodiments further comprise fifth means for forming a seal between the fourth means and at least one of the first and second means.
- In some embodiments, the first means comprises a filling member, the second means comprises a tip of the filling member, the third means comprises at least one port, the fourth means comprises a closure, and the fifth means comprises a sealing member.
- In accordance with another aspect, a method comprises the following steps:
- (i) penetrating a first penetrable septum with a first needle or like injection member and placing the first needle or like injection member into fluid communication with a sealed, empty chamber;
- (ii) introducing a substance through the first needle or like injection member and into the chamber;
- (iii) withdrawing the first needle or like injection member from the first penetrable septum; and
- (iv) sealing a resulting penetration aperture in the first needle penetrable septum with a second needle penetrable septum.
- In some embodiments, the method further comprises the steps of:
- (v) penetrating the second needle penetrable septum and the first needle penetrable septum with a second needle or like injection member and into fluid communication with the substance in the chamber, and
- (vi) withdrawing substance from the chamber through the second needle or like injection member.
- In some embodiments, the method further comprises, prior to closing a resulting penetration aperture in the first septum with the second septum, sterilizing at least an exterior surface of the first penetrable septum defining the resulting penetration aperture and an interior surface of the second penetrable septum, such as with UV radiation (e.g., at a wavelength of about 254 nm), or low energy beta radiation, or by any sterilizing agent. In some such embodiments, the sterilizing step includes applying radiation to said surfaces. In some such embodiments, the step of sterilizing the sealed empty chamber is performed prior to penetrating the first penetrable septum.
- In some embodiments, the penetrating step further comprises wiping the first needle or like injection member with the first penetrable septum. In some such embodiments, the wiping step comprises wiping the tip of the filling needle or like injection member with the first penetrable septum. In some such embodiments, the wiping step comprises wiping the needle or like injection member with the first penetrable septum defining a durometer within the range of about 5 Shore A to about 65 Shore A. In some other such embodiments, the wiping step comprises wiping the needle or like injection member with the first penetrable septum defining a thickness within the range of about ½ to about two times the largest diameter of the needle or like injection member. In other such embodiments, the wiping step comprises wiping the tip of the needle or like injection member, wherein the tip defines an included bevel angle within the range of about 30 degrees to about 50 degrees, such as about 40 degrees. In some such embodiments, the wiping step achieves at least about a 3 log reduction in bio-burden on the tip of the needle or like injection member.
- In some embodiments, the sealing step includes moving the second penetrable septum from a first position, wherein a first portion thereof overlies the first penetrable septum, to a second position, wherein a second portion thereof overlies and sealingly engages the first penetrable septum. In other embodiments, the sealing step includes moving the second penetrable septum from a first position spaced away from the first penetrable septum to a second position overlying and sealingly engaging the first penetrable septum.
- In accordance with another aspect, a method comprises the following steps:
-
- (i) penetrating a first penetrable septum with a first needle or like injection member and placing the first needle or like injection member into fluid communication with a sealed, empty chamber;
- (ii) prior to or during the penetrating step, moving at least one of a closure and at least one filling port of the first needle or like injection member from a closed position closing the at least one filling port to an open position opening the at least one filling port;
- (iii) introducing a substance through the first needle or like injection member and into the chamber; and
- (iv) withdrawing the first needle or like injection member from the first penetrable septum.
- The substance can be introduced from the first needle or like injection member into the chamber after full perforation of the first penetrable septum or after part of the at least one filling port has passed through an interior surface of the first penetrable septum and is located within the chamber. The method can further comprise the step of substantially sealing the at least one filling port and an interior of the needle or like injection member from ambient atmosphere in the closed position. The method can also comprise, before or during the withdrawing step, moving at least one of the closure and the at least one filling port of the first needle or like injection member from the open position to the closed position. During the penetrating and withdrawing steps, the method can include substantially preventing any contact between the at least one filling port and the first penetrable septum. In some embodiments, the closure is interposed between the at least one filling port and first penetrable septum to substantially prevent any contact between the at least one filling port and the first penetrable septum.
- One advantage of the present invention is that the device, such as a container to be filled, is mechanically self-closing. As a result, the present invention obviates the need to thermally, chemically or laser reseal the resulting penetration aperture, and thus obviates the need for such additional processing steps and equipment. Another advantage is that the septum is configured to wipe the tip of the filling needle or like injection member as it penetrates the septum to fill the chamber, and effectively de-contaminates and/or sterilizes the tip prior to entry into the chamber. Accordingly, another advantage of the present invention is that it can reduce the risk of contamination and/or reduce the controls over, or the need to control a filling needle environment. Another advantage is the absolute protection of the product or substance to be filled from exposure to the environment. The needle opens and closes automatically within the sterile or aseptic container. The needle is always closed prior to being withdrawn from within the sterile container. As a result, the needle is sealed during passage through the septum to prevent any contaminants on the septum or in the environment from contaminating the interior of the needle.
- Other objects and advantages of the present invention, and/or of embodiments thereof, will become more readily apparent in view of the following detailed description and the accompanying drawings.
-
FIG. 1 is a side perspective view of a device in the form of a container; -
FIGS. 2A-2D sequentially show the assembly of the device ofFIG. 1 , in which the septa are over-molded onto the molded cap and the first closure is sealingly closed in place on the container; -
FIG. 3A is a partial, side cross-sectional side view of the device ofFIG. 1 , with the second closure in the first, non-sealing position; -
FIG. 3B is a side cross-sectional view of the device ofFIG. 1 after the filling member has pierced the device septum and has been withdrawn leaving a hole in the device septum, with the second closure in the first, non-sealing position, and schematically showing sterilization of the first and second closures; -
FIG. 4 is a side cross-sectional view of the device ofFIG. 1 , with the second closure in the second, sealing position; -
FIG. 5 is a side perspective view of a filling device engageable with the device ofFIG. 1 to aseptically or sterile fill a substance therein; -
FIG. 6A is a side cross-sectional view of the filling device ofFIG. 5 , with the closure in the first or closed position, sealing the ports of the filling member from the ambient atmosphere; -
FIG. 6B is a side cross-sectional view of the filling device ofFIG. 5 , with the closure in the second or open position, opening the ports of the filling member; -
FIG. 7A is a partial, side cross-sectional view of the closure and tip of the filling device ofFIG. 5 prior to engagement with the septum of the device ofFIG. 1 , with the closure in the first or closed position sealing the ports from ambient atmosphere; -
FIG. 7B is a side cross-sectional view of the filling device ofFIG. 5 upon penetration of the tip of the filling member through a septum of the type shown inFIG. 1 , with the closure still in the first or closed position sealing the ports from contact with the penetrated septum; -
FIG. 7C is a side cross-sectional view of the filling device ofFIG. 5 , where the tip of the filling member is penetrated through the septum, the closure is prevented from further movement through the septum, and the filling member is allowed to continue to move into the chamber relative to the fixed closure to expose the fluid ports to the chamber and allow the aseptic or sterile flow of substance through the open ports and into the aseptic or sterile chamber; -
FIG. 8A is a side cross-sectional view of another embodiment of the distal end of the filling device ofFIG. 5 , including a seal over-molded to the stop surface formed at the tip of the filling member to facilitate forming a substantially fluid-tight or hermetic seal between the closure and filling device; -
FIG. 8B is a side cross-sectional view of another embodiment of the distal end of the filling device ofFIG. 5 , including a seal over-molded to the distal end of the closure to facilitate forming a substantially fluid-tight or hermetic seal between the closure and filling device. -
FIG. 9A is a top perspective view of a device in the form of a container, with the second closure in the first, non-sealing position; -
FIG. 9B is a top perspective view the device ofFIG. 9A with the second closure in the first, non-sealing position with a filling member positioned to pierce the first closure; -
FIG. 9C is a side view of the device ofFIG. 9A that has been filled, with the second closure in the second, sealing position and ready for sampling of substance in the chamber; -
FIG. 9D is a side view of the filled device ofFIG. 9C with a needle piercing the second closure into the chamber to permit withdrawal and sampling of substance from the chamber; -
FIG. 9E is a side view of the device ofFIG. 9C with all of the substance withdrawn from the chamber; -
FIG. 10A is a cross-sectional view of the device and filling member shownFIG. 9B ; -
FIG. 10B is a cross-sectional view of the device ofFIG. 9A with the tip of the filling member penetrating the septum of the first closure into the chamber and the closure of the filling member in the first or closed position, sealing the ports of the filling member from the ambient atmosphere; -
FIG. 10C is a cross-sectional view of the device ofFIG. 9A with the filling member further penetrating into the chamber with the closure of the filling member in the second or open position, opening the ports of the filling member; -
FIG. 10D is a cross-sectional view of the device ofFIG. 9A with the filling member partially withdrawn from the chamber and the closure of the filling member moved back to the first or closed position, re-sealing the ports of the filling member from the ambient atmosphere; -
FIG. 11 is an exploded view of another embodiment of a device in the form of a container; -
FIGS. 12A-12D show sequential side cross-sectional views of the assembly, sterilization, filling and sealing of the device ofFIG. 11 taken along section line A-A; -
FIG. 13 is a perspective cross-sectional view of another embodiment of a device in the form of a container, prior to assembly of the second septum thereto; -
FIG. 14 is a perspective cross-sectional view of the device ofFIG. 13 , with the second septum in a first, ready for filling, position; -
FIG. 15 is a perspective cross-sectional view of the device ofFIG. 13 during filling thereof; -
FIG. 16 is a perspective cross-sectional view of the device ofFIG. 13 , with the second septum in a second, sealing, position; -
FIG. 17 is a perspective cross-sectional view of another embodiment of a device in the form of a container, prior to assembly of the septum thereto; -
FIG. 18 is a perspective cross-sectional view of the device ofFIG. 17 , with the septum in a first, ready for filling, position; -
FIG. 19 is a perspective cross-sectional view of the device ofFIG. 17 during filling thereof; -
FIG. 20 is a perspective cross-sectional view of the device ofFIG. 17 with the septum in a second, sealing, position; -
FIG. 21 is an exploded view of another embodiment of a device in the form of a container; -
FIG. 22 is a perspective side view of the device ofFIG. 21 , with the closure in the first position, uncovering the filling septum; and -
FIG. 23 is a perspective side view of the device ofFIG. 21 , with the closure in the second position, uncovering the withdrawal septum. - In
FIG. 1 a device is indicated generally by thereference numeral 10. In the illustrated embodiment, thedevice 10 is a container defining a sealed (with respect to the ambient atmosphere or environment)empty chamber 11 therein for aseptic or sterile filling with a substance, such as a medicament, pharmaceutical injectable, or vaccine. However, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the invention may be embodied in and otherwise may be applicable to any of numerous different types of devices that are currently known or that later become known, such as vials, syringes, delivery devices, dispensers and processing devices. Similarly, the devices may be filled with any of numerous different substances that are currently known or that later become known, such as medicaments, pharmaceutical injectables, vaccines, supplements, foods, beverages, liquid nutrition products, and industrial products, and in any of numerous different forms, including liquids, gels, powders and gases. - As shown in
FIG. 1 , thecontainer 10 includes abody 12 and aclosure 14. In the illustrated embodiment, the body is substantially cylindrical and defines a substantiallycylindrical sidewall 16 with anopening 18 at a top end thereof, for sealingly receiving theclosure 14 thereon, as described further below. Thebody 12 further includes anannular projection 20 spaced from the top end thereof and extending laterally outwardly from thesidewall 16. Thebody 12 may be made of glass or plastic. However, as may be recognized by those of ordinary skill in the pertinent art based on the teaching herein, the body may be made of any of numerous different materials that are currently known or that later become known. As also may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the body may be configured in any of numerous shapes to receive a closure. For example, the body may define a spool-like or “diabolo” shape such as disclosed in U.S. Pat. No. 7,100,646, issued Sep. 5, 2006, entitled “Sealed Containers and Methods of Making and Filling Same,” which, in turn, claims benefit of similarly titled U.S. Provisional Patent Application No. 60/408,086, filed Sep. 3, 2002, each of which is hereby expressly incorporated by reference in its entirety as part of the present disclosure. - As shown in
FIGS. 2A-2D , theclosure 14 comprises afirst closure 22 and asecond closure 24. The first andsecond closures living hinge 26. However, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the second closure may be connected to either of the first closure or body via any of numerous connections that are currently known or that later become known to allow movement of at least one of the closures relative to the other. Similarly, the first andsecond closures second closures - Both the first and
second closures penetrable septums penetrable septums second closure portions penetrable septums second closure portions FIGS. 2A and 2B . Thesecond closure portion 24 can then be mounted onto thebody 12 as shown inFIGS. 2C and 2D . However, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the penetrable septums may be mounted within the first and second recesses in any of numerous ways configured to sealingly mount the septums therein, and the container may be assembled in a different order. For example, theclosure 14 may be mounted on thebody 12, and then theseptums second closure portions - As shown in
FIG. 3A , thefirst closure 22 includes anannular sidewall 36 axially extending from the perimeter of the top surface thereof, defining an axially extendingannular channel 38 between theannular sidewall 36 and the annular wall of theannular recess 28. Theannular channel 38 receives therein a portion of the top end of thecylindrical sidewall 16 of thebody 12, when the first closure is mounted atop the body. The top end of thecylindrical sidewall 16 of the body defines an annular taperedprotuberance 40. As can be seen, the taperedprotuberance 40 defines a taperedsurface 42 on an external side of thesidewall 16. Directly adjacent to the body taperedprotuberance 40, opposite the top end of the body, thebody sidewall 16 defines a laterally extendingannular recess 44, extending inwardly from the exterior of the sidewall. - The bottom end of the
annular sidewall 36 of the first closure defines a corresponding annular taperedprotuberance 46. As can be seen, the taperedprotuberance 46 defines a taperedsurface 48 on the interior of thesidewall 36. Thus, when thefirst closure 22 is mounted atop thebody 12, a portion of the sidewall at the top end of the body is received within the axially-extendingannular channel 38 of the first closure, and the annular taperedprotuberance 46 of the first closure slides past the opposing annular taperedprotuberance 40 of the body and snaps into the laterally-extendingannular recess 44 of the body to create a fluid-tight seal therebetween. Anotherannular recess 50 is defined between the bottom end of the first closure and the laterally-extendingannular projection 20 of the body. - When the
first closure 22 is sealingly mounted atop thebody 12, the sealedempty chamber 11 is defined within the body, and the firstpenetrable septum 32 is in fluid communication with the chamber. If theclosure 14 andbody 12 are sterilized, a sealed, empty, sterile chamber is thus defined therein. Sterilization of the closure, body and/or any component parts therein may be achieved in accordance with the teachings of any of the following patents and patent applications, each of which is hereby expressly incorporated by reference in its entirety as part of the present disclosure as if fully set forth herein: U.S. patent application Ser. No. 08/424,932, filed Apr. 19, 1995, entitled “Process for Filling a Sealed Receptacle under Aseptic Conditions,” issued as U.S. Pat. No. 5,641,004; U.S. patent application Ser. No. 09/781,846, filed Feb. 12, 2001, entitled “Medicament Vial Having a Heat-Sealable Cap, and Apparatus and Method for Filling Vial,” issued as U.S. Pat. No. 6,604,561, which, in turn, claims benefit of U.S. Provisional Patent Application No. 60/182,139, filed Feb. 11, 2000, entitled “Heat-Sealable Cap for Medicament Vial;” U.S. patent application Ser. No. 10/655,455, filed Sep. 3, 2003, entitled “Sealed Containers and Methods of Making and Filling Same,” issued as U.S. Pat. No. 7,100,646, which, in turn, claims benefit of similarly titled U.S. Provisional Patent Application No. 60/408,068, filed Sep. 3, 2002; and U.S. patent application Ser. No. 10/766,172, filed Jan. 28, 2004, entitled “Medicament Vial Having a Heat-Sealable Cap, and Apparatus and Method for Filling the Vial,” issued as U.S. Pat. No. 7,032,631, which, in turn claims benefit of similarly titled U.S. Provisional Patent Application No. 60/443,526, filed Jan. 28, 2003 and similarly titled U.S. Provisional Patent Application No. 60/484,204, filed Jun. 30, 2003. In addition, the sealed empty chamber may be sterilized with a fluid sterilant prior to filling, as disclosed in U.S. patent application Ser. No. 13/529,951, filed Jun. 21, 2012, entitled “Fluid Sterilant Injection Sterilization Device and Method,” which, in turn, claims the benefit of U.S. Provisional Patent Application No. 61/499,626, filed Jun. 21, 2011, entitled “Nitric Oxide Injection Sterilization Device and Method,” each of which is hereby expressly incorporated by reference in its entirety as part of the present disclosure as if fully set forth herein. - With the
first closure 22 mounted atop thebody 12, thesecond closure 24 is moveable between a first position (shown inFIGS. 2D , 3A, 9A and 10A), spaced away from thefirst closure 22, and a second position (shown inFIG. 4 ), where thesecond closure 24 mounts atop thefirst closure 22. In the first position, the secondpenetrable septum 34 is not sealingly engaging the firstpenetrable septum 32. In the second position, on the other hand, the secondpenetrable septum 34 sealingly overlies the penetrable portion of the firstpenetrable septum 32, thus creating a mechanical seal, as explained further below. - As shown in
FIG. 2B , thesecond closure 24 includes anannular sidewall 52 axially extending from the perimeter of the top surface thereof, and is configured to fittingly receive thefirst closure 24 therein when in the second position. The bottom end of the second closureannular sidewall 52 defines an annular taperedprotuberance 54. As can be seen, the taperedprotuberance 54 defines a taperedsurface 56 on the internal side of thesidewall 52. When thesecond closure 24 is moved from the first position to the second position, the first closure is fittingly received within the second closure, the bottom end of the second closure abuts the laterally-extendingannular projection 20 of the body, and the annular taperedprotuberance 54 of the second closure snaps into theannular recess 50 between the bottom end of the first closure and the laterally-extending annular projection to secure the second closure in the second position. - When in the second position, the second axially-extending
recess 30 of thesecond closure 24, containing the secondpenetrable septum 34 therein, sealingly fits within the firstpenetrable septum 32, thereby sealingly engaging the second penetrable septum atop the penetrable portion of the first penetrable septum. In the illustrated embodiment, as shown inFIG. 4 , the firstpenetrable septum 32 is approximately dome or convex shaped on a side thereof opposite thechamber 11. The secondpenetrable septum 34 is correspondingly approximately dome or convex shaped as well on a side thereof substantially opposite the firstpenetrable septum 32, in order to sealingly mate with the contour of the first penetrable septum. - In order to fill the
device 10 with a substance, a filling device penetrates the firstpenetrable septum 32, when thesecond closure 24 is in the second or open position. An exemplary needle is disclosed in U.S. patent application Ser. No. 13/450,306, filed Apr. 18, 2012, entitled “Needle with Closure and Method,” which, in turn, claims benefit of U.S. Provisional Patent Application No. 61/476,523, filed Apr. 18, 2011, entitled “Filling Needle and Method,” each of which is hereby expressly incorporated by reference in its entirety as part of the present disclosure as if fully set forth herein. - In some embodiments, a filling
device 60, as shown inFIG. 5 , is utilized to fill thedevice 10. The fillingdevice 60 comprises a hollow fillingmember 62, atip 64 formed at one end of the filling member, twoports 66 in fluid communication with the interior of the hollow fillingmember 62, a first or relativelyrigid closure 68, and a second closure or relatively flexibleannular shell 70. The fillingmember 62 includes aboss 72 at approximately a middle portion thereof. As can be seen, theboss 72 defines an annularly and axially extending recess therein for receiving a proximal portion of theclosure 68 and a biasingmember 74 that engages and biases the closure, as described further below. In the illustrated embodiments, the twoports 66 are diametrically opposed relative to each other; however, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the filling device may define any number of ports that may define any of numerous different configurations and locations. - The
closure 68 and/or the fillingmember 62 is movable between (i) a first position wherein the closure closes theports 66, as shown typically inFIG. 6A , and (ii) a second position opening theports 66, as shown typically inFIG. 6B . When in the closed position, theclosure 68 forms a substantially fluid-tight seal between theports 66 and ambient atmosphere. Theclosure 68 is biased via the biasingmember 74 in the direction from the second or open position toward the first or closed position to normally close theports 66. In the illustrated embodiment, the biasingmember 74 is a coil spring. However, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the closure may be biased in any of numerous different ways that are currently known or that later become known, using biasing members other than springs. Further, if a spring is used, any of numerous different springs or combinations of springs may be used. In the illustrated embodiment, theclosure 68 is a “shutter” closure that slides axially over the fillingmember 62 between the normally closed and open positions. However, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the closure may take any of numerous different configurations that are currently known, or that later become known, for performing the function of the closure as described herein. - The
closure 68 extends both annularly and axially about the fillingmember 62 and is slidably mounted on the filling member. Theclosure 68 includes anannular flange 76 adjacent to a proximal end thereof that is engageable with the biasingmember 74 for biasing the closure in the direction from the second or open position toward the first or closed position. An opposingdistal end 78 of theclosure 68 is engageable with anannular stop surface 80 of the fillingmember tip 64 to stop the closure in the first or closed position. Thedistal end 78 of theclosure 68 tapers inwardly to define a perimeter substantially flush with the perimeter of thestop surface 80 and adjacent portion of the fillingmember tip 64. As shown inFIGS. 8A and 8B , in alternative embodiments, the closure 68 (FIG. 8B ) and/or the filling member tip 64 (FIG. 8A ) includes anannular seal 82, between thedistal end 78 of the closure and thetip 64 of the filling member, to further ensure the formation of a fluid-tight seal at the junction of the closure and filling member. In the embodiment ofFIG. 8A , theseal 82 is o-ring shaped and is over-molded to the fillingmember tip 64. In the alternative embodiment ofFIG. 8B , the O-ring shapedseal 82 is over-molded to the distal tip of theclosure 68. As may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the seal may or may not be integral with the closure and may take the form of any of numerous different types of seals or sealing members that are currently known or that later become known, to facilitate the formation of fluid-tight seal at the juncture of the closure and filling member. In the illustrated embodiment, the proximal end of theclosure 68 is slidably received within the annular recess of theboss 72 of the fillingmember 62, and the biasingmember 74 is located between therear wall 84 of theboss 72 and theannular flange 76. - The flexible closure or
shell 70 sealingly encloses theboss 72 of the fillingmember 62. In the illustrated embodiment, the flexible shell forms a bellows to allow the shell to axially expand when moving into the first or closed position (FIG. 6A ) and to axially contract when moving into the second or open position (FIG. 6B ). However, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the flexible shell may take any of numerous different configurations that are currently known, or that later become known, for performing the function of the shell as described herein. The flexible shell sealingly engages an outwardly projectingannular flange 86 of theboss 72 near the proximal end thereof, and sealingly engages anannular flange 88 of theclosure 68 at the distal end thereof. In the illustrated embodiment, the closureannular flange 88 projects radially outwardly from an approximate mid-portion of theclosure 68. The portion of theflexible shell 70 proximally adjacent to the bossannular flange 86 includes an integrally theboss 72. Theboss 72 includes corresponding venting holes 92 located adjacent to therear wall 84 that are normally sealed by thevalve 90. The venting holes 92 are in fluid communication with the interior recess of theboss 72. The interior of theboss 72 is in fluid communication with one or more annularly and axially extending channels formed between theclosure 68 and fillingmember 62 which, as shown inFIGS. 7C and 10C , are in fluid communication with a chamber to be filled when the closure is located in the second or open position. Thus, when the biasingmember 74 is compressed upon movement of the closure from the first position to the second position, sufficient fluid pressure within the boss 72 (i.e., at or above the venting valve opening pressure) will cause the ventingvalve 90 to move radially outwardly relative to theholes 92 to thereby allow one-way venting of any such air or other gases into the ambient atmosphere. In addition, as described further below, during filling, any air or other gases (e.g., nitrogen) that are displaced from the chamber to being filled are allowed to vent through the channels between the closure and filling member and, in turn, through the ventingvalve 90. When the pressure equalizes, thevalve 90 resiliently returns to its sealing position overlying and engaging theholes 92. In similar fashion, the ventingvalve 90 allows one-way venting of air or other gases through the venting holes 92, and into theshell 72 when a vacuum is present therein. As may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the venting valve may take the form of any of numerous integral or non-integral valves, that are currently known or that later becomes known, capable of performing the function of the venting valve as described herein. - In the illustrated embodiment, the filling
device tip 64 is defined by a non-coring, conically-pointed tip; however, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the filling device tip may define any of numerous other tip configurations that are currently known, or that later become known, such as a trocar tip. In one configuration, the spring force of the biasingmember 74 is sufficient to allow the fillingdevice 60 to penetrate a septum of an opposing device while maintaining theclosure 68 in the closed position during penetration of the closure through the septum and until theannular flange 88 of the closure engages an exterior surface of the septum (or other exterior or stop surface of the device to be filled) to cause relative movement of the closure and filling member against the bias of the biasingmember 74 from the normally closed position to the open position and, in turn, expose the sterilefilling device ports - A filling line attachment fitting 94 is formed on a proximal end of the filling
member 62. In the illustrated embodiment, the attachment fitting 94 is a barbed fitting for attachment to a filling line (not shown). As may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, any of numerous different types of fittings, connections or connectors that are currently known, or that later become known, equally may be employed for connecting the filling device to a filling or other type of line or conduit. For example, the proximal end of the filling device may define a male or a female connector for aseptically or sterile connecting to the other of the male or female connector attached to a filling line, as disclosed in U.S. patent application Ser. No. 13/864,919, filed May 1, 2013, entitled “Device for Connecting or Filling and Method,” which, in turn, claims benefit of similarly titled U.S. Provisional Application No. 61/794,255, filed Mar. 15, 2013, and similarly titled U.S. Provisional Patent Application No. 61/641,248, filed May 1, 2012; and U.S. patent application Ser. No. 13/864,919, filed Apr. 17, 2013, entitled “Self Closing Connector,” which, in turn, claims benefit of similarly titled U.S. Provisional Patent Application No. 61/784,764, filed Mar. 14, 2013, similarly titled U.S. Provisional Patent Application No. 61/635,258, filed Apr. 18, 2012, and similarly titled U.S. Provisional Patent Application No. 61/625,663, filed Apr. 17, 2012, each of which is hereby expressly incorporated by reference in its entirety as part of the present disclosure as if fully set forth herein. - The filling
device 60 may be used to aseptically or sterile fill fluids through the firstpenetrable septum 32 and into thechamber 11 of thedevice 10. As shown inFIGS. 7A , 9B and 10A, prior to penetrating thefirst septum 32, and when the fillingdevice tip 64 is exposed to the ambient atmosphere, theclosure 68 is in the closed position sealing theports 66 with respect to ambient atmosphere to thereby maintain the sterility of the ports and of the interior of the filling device. As shown inFIGS. 7B and 10B , upon penetrating thefirst septum 32, theclosure 68 remains interposed between theports 66 and the firstpenetrable septum 32 to substantially prevent contact between the ports and the septum. When theports 66 are located within thechamber 11, the bottom surface of theannular flange 88 of the closure engages the top surface of thefirst closure 22 and prevents further movement of theshutter closure 68 relative to thefirst closure 22. Further penetration of the fillingdevice 60 into the chamber of thedevice 10 causes the fillingmember 62 and fillingdevice tip 64 to slide relative to theshutter closure 68 against the bias of the biasingmember 74 to, in turn, move theports 66 to the open position. As the biasingmember 74 is compressed with further movement of the shutter closure from the closed position to the open position, any fluid pressure within theshell 72 above of the venting valve opening pressure is allow to flow through the ventingvalve 90 into the ambient atmosphere. In the open position ofFIGS. 7C and 10C , the fluid or other substance within the filling device is permitted to flow through theopen ports 66 and into thechamber 11. Any fluid within thechamber 11 that is displaced by the substance flowing into the chamber is allowed to vent through the channels formed between theshutter enclosure 68 and fillingdevice 62 and, in turn, through the ventingvalve 90. Since thesterile ports 66 are never exposed to the ambient atmosphere throughout the filling process, the ports, interior of the filling device, and fluid flowing therethrough, are not contaminated and/or are maintained aseptic or sterile as the fluid is injected or otherwise filled into thechamber 11. - In some embodiments, the
first septum 32 comprises a lower, i.e., base, layer having a relatively high durometer and an upper layer having a relatively lower durometer. In some such embodiments, the upper layer is not bondable with the lower layer and is over-molded thereon. In some such embodiments, thefirst septum 32 wipes thetip 64 of the fillingmember 62 and theshutter closure 68 of contaminants thereon during engagement and penetration of the septum by the tip to, in turn, prevent the tip and/or shutter closure from introducing such contaminants into the sterile interior of thechamber 11 and thereby maintain the chamber and any substance therein aseptic or sterile. The effectiveness of such wiping during penetration of the septum is dependent, in part, upon the pressure applied by the septum onto the tip of the filling member as it penetrates through, as well as the coefficient of friction therebetween. - Several factors affect the pressure applied by the septum onto the tip. As stated above, the
first septum 32 is approximately dome or convex shaped. The present inventor has determined that the dome or convex shape increases the internally directed pressure applied by theseptum 32 onto thetip 64 from the beginning of piercing, as the tip inverts the convexity of the septum in order to penetrate therethrough. Additionally, the thickness of the septum (increasing the length of the wiping effect) and durometer thereof also affect the pressure applied by the septum onto the tip. In some embodiments, the durometer of theseptum 32, or the layers thereof, is within the range of about 5 Shore A to about 65 Shore A, such as, for example, within the range of about 20 Shore A to about 50 Shore A. In some such embodiments, the durometer of theseptum 32 is within the range of about 25 Shore A to about 45 Shore A. In some such embodiments, the septum thickness is within the range of about ½ to about two times the largest diameter of thetip 64 of the fillingmember 62. - The material of the filling
member 62 and theseptum 32 also may be selected to enhance the wiping effect. The present inventor has determined that the use of a plastic filling member provides the appropriate friction coefficient range to enhance the wiping effect. Advantageously, the plastic material is also easier to mold, and thus easier to manufacture and assemble. A septum made of a homogeneous elastic material defining a substantially homogeneous density will enhance the wiping effect. In some embodiments, the fillingmember 62 is formed of plastic, such as any of numerous different thermoplastics, including the liquid crystal polymers (LCP) that are highly crystalline, thermotropic (melt-orienting) thermoplastics and sold under the trademark Vectra™ by Celanese Corporation, or graphene. In some such embodiments, thefirst septum 32 is made of silicone. In other embodiments, thefirst septum 32 is made of a vulcanized rubber or a thermoplastic elastomer. However, as may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the filling member and septum may be made of any of numerous different materials that are currently known, or that later become known, to perform the functions of the filling member and septum disclosed herein. - The configuration of the filling member itself also enhances the effectiveness of the wiping effect. The included angle of the
tip 64 of the filling member affects the progressively increasing thickness of the tip, and the diameter of the filling device, i.e., the outer diameter of the shutter closure. As the fillingmember 62 penetrates through thefirst septum 32, the internal pressure applied by the septum onto thetip 64, and thereafter onto a portion of the rigid closure increases proportionally to the progressively increasing tip diameter, resulting from the included angle of the tip. In some embodiments, the included angle of the tip of the piercing member is within the range of about 20 degrees to about 40 degrees, and such as about 30 degrees. - The present inventor has determined that the wiping effect on a filling member tip by a septum having properties as aforementioned may achieve at least approximately a 3 log reduction in bio-burden when filling member tip penetrates a septum while immersed in a broth, which is about the reduction achieved by known UV pulse (5 second) sterilization techniques, and up to approximately a 6 log reduction in bio-burden. Therefore, one advantage of the present invention is that the wiping of the filling device tip allows substantially sterile filling of fluids within a non-aseptic, non-sterile or relatively low sterility assurance level (“SAL”) environment (e.g., about 6 log bio-burden or lower).
- Another advantage is that the filling
device 60 may sterile fill a substance into thedevice 10 without the need to decontaminate the septum of the device or the tip of the filling device prior to filling. The combination of the maintained sterility of theports 66 and interior of the fillingdevice 60, as well as the wiping effect provided by thefirst septum 32 effectively sterilize thetip 64 of the fillingmember 62 upon penetration of the filling member through the septum. Therefore sterile filling is achieved without the need to take conventional sterilization steps, such as the application of UV radiation, for example. Thus, the combination of the maintained sterility of theports 66 and interior of the filling device, as well as the wiping effect provided by thefirst septum 32, allows substantially sterile filling to be achieved in an unclassified environment (e.g., about log 6 or higher), as explained in U.S. Provisional Patent Application No. 61/798,210, filed Mar. 15, 2013, entitled “Controlled Non-Classified Filling Device and Method,” which is hereby expressly incorporated by reference in its entirety as if fully set forth herein. As should be understood by those of ordinary skill in the pertinent art, an unclassified environment is an environment having a number and size of particles per volume greater than 100,000 particles per cubic meter of 0.5 μm or larger in diameter, i.e., a class 100,000 environment. - As shown in
FIG. 10D , after thechamber 11 is filled as desired, the fillingdevice 60 is withdrawn from thefirst septum 32. As the filling device is withdrawn, the biasingmember 74 biases therigid closure 68 downwardly or in the direction of theseptum 32. Therefore, as the fillingmember 62 is withdrawn, it is moved axially relative to theshutter closure 68 to, in turn, move theports 66 into the closed position behind the closure. Theshutter closure 68 is configured to substantially prevent contact between the filling device eyes orports 66, and as can be seen, the sliding shutter or closure is closed over the filling device eyes or ports prior to their passage through the septum and/or withdrawal therefrom. When thedistal end 78 of theclosure 68 sealingly reengages thestop surface 80 of thefilling device tip 64, the closure is in the closed position, and is maintained in the closed position by the downward force or bias of the biasingmember 74. Thus, during, upon, and before, withdrawal of the fillingdevice 60 from thefirst septum 32, theclosure 68 sealingly closes theports 66 and prevents contamination of the ports or interior of the filling device. - The
first septum 32 is engineered in a manner known to those of ordinary skill in the pertinent art to self-close and thereby ensure that the head loss left by the residual filling device injection aperture 96 after the tip of the filling device is withdrawn substantially prevents fluid ingress therethrough. Thereafter, as shown inFIG. 4 , thesecond closure portion 24 is moved from the first position, and snaps into the second position, and the unpenetratedsecond septum 34 overlies and seals the injection aperture 96 in thefirst septum 32 from the ambient atmosphere. This forms a filled, sealed device as shown inFIGS. 4 and 9C . Prior to moving thesecond closure 34 from the first position to the second position, the exterior surface of thefirst closure 32 and/or the interior surface of thesecond closure 24 may be sterilized, such as is shown in the example ofFIG. 3B , in order to prevent any contaminants from being trapped between the first andsecond septums - If desired, a further closure may be applied over the
second closure 24 and/orsecond septum 34, such as an adhesive-backed foil layer that overlies thesecond septum 24 and is adhesively attached to the second septum or second closure, to provide an additional barrier such as to prevent moisture-vapor transmission (“MVT”). When ready for use, the adhesive-back foil layer or other additional MVT barrier may be manually engaged and removed to expose the second septum. Then, as shown inFIG. 9D , a syringe needle or like withdrawal device may be pierced through the first andsecond septums interior chamber 11 and the fluid or other substance therein to withdraw the fluid or other substance from the chamber and into the syringe to, for example, inject the withdrawn substance into a person. In some embodiments, the first and second septums may be pierced one or more times as desired to withdraw substance from thechamber 11 until the chamber is empty as shown inFIG. 9E . - In another embodiment, the second closure is initially a separate piece and is not connected to the first closure. After the first closure is pierced and the device is filled with a substance, the second closure is then fixedly secured, such as by a snap fit as described above, to the first closure to sealingly engage the first and second septums, and seal the resulting penetration aperture in the first septum. The second closure can be pre-sterilized prior to assembly, or can be surface sterilized as described above prior to assembly to the first closure. The second closure can be automatically assembled to the first closure with any of numerous different assembly devices that are currently known, or that later become known, such as a pick and place robotic assembly device, or other suitable fixture that can automatically assemble the second closure to the first closure. A closure assembly station can be located downstream of the needle penetration and filling station to assemble the second closure to the first closure upon or following withdrawal of the filling needle from the first closure.
- In
FIGS. 11-12D , another device is indicated generally by thereference numeral 110. Thedevice 110 is substantially similar to thedevice 10 described above in connection withFIGS. 1-4 and 9A-10B, and therefore like reference numerals preceded by the numeral “1” are used to indicate like elements. A primary difference of thedevice 110 in comparison to thedevice 10 is the design of theclosure 114 and that the firstpenetrable septum 132 is not integrated into theclosure 114. Rather, the firstpenetrable septum 132 is separate from the closure and seats into theopening 118 of thebody 112. When theclosure 114 mounts atop thebody 112, alower portion 122 of theclosure 114 sealingly clamps the firstpenetrable septum 132 into thebody opening 118. Anupper portion 124 of theclosure 114 defines a laterally-extendingslot 124 a configured to slidably receive the secondpenetrable septum 134 therein, for sealing thefirst septum 132 after penetration thereof, as hereinafter described. - As shown in
FIG. 11 , thebody 112 includes an annular, laterally-extendingflange 120 spaced from theopening 118, and aneck 113 extending upward from the periphery of theflange 120 to theopening 118. Thefirst septum 132 includes a corresponding annular, laterally-extendingflange 132 a dimensioned for engagement with theflange 120 of thebody 112. Theseptum 132 also includes an annular, axially-extendingportion 132 b, spaced radially inwardly relative to theflange 132 a and projecting axially downwardly therefrom. When thefirst septum 132 is mounted into theopening 118 of thebody 112, theportion 132 b extends toward thechamber 111 of the device and sealingly engages the interior surface of thebody sidewall 116 and theflange 132 a engages theflange 120. Theclosure 114 is mounted atop thefirst septum 132, and onto thebody 112, to form a compression seal between theclosure 114,first septum 132, andbody 112. - The
lower portion 122 of theclosure 114 defines a substantially annularlateral slot 122 a therein defining a substantially annularinner sidewall 136. The ceiling 122 b ofslot 122 a, i.e., the base of theupper portion 124, defines afirst aperture 128 extending between the lower andupper portions sidewall 136 of theslot 122 a includes anannular lip 136 a extending laterally inwardly from the base end of thesidewall 136. Thelip 136 a is slightly smaller in diameter than theneck 113. When theclosure 114 is mounted atop thebody 112, theslot 122 a receives theneck 113 and thefirst septum 132 therein. Thelip 136 a is flexed slightly outwardly by thelarger neck 113 during mounting so it can slide over and past theneck 113. After thelip 136 a slides past the bottom of the neck, thelip 136 a resiliently returns to its original size and engages the bottom surface of theflange 120 of thebody 112, in a snap-fit type engagement, to hold theclosure 114 in place. In some embodiments, theneck 113 of thebody 112 defines a slot (not shown) adapted to receive therein a corresponding tab (not shown) projecting from the interior surface of theclosure 114, such that theclosure 114 only mounts onto thebody 112 when the tab and slot align, in a key-and-groove type configuration. Thus, theclosure 114 only mounts ontobody 112 in a designated orientation relative thereto. - The height of the
slot 122 a, i.e., the distance between the ceiling 122 b and thelip 136 a is approximately the same as the height of theneck 113. However, the height of theslot 122 a is slightly less than the height of portion of thefirst septum 132 to be retained in theslot 122 a. Once mounted, then, the ceiling 122 b of theslot 122 a abuts the upper surface of thefirst septum 132 and compresses and/or depresses thefirst septum 132 into theneck 113 and, in turn, creates a compression seal between theclosure 114, theseptum 132 and thebody 112. Similar to the embodiment described above, thefirst septum 132 is approximately dome or convex shaped on the upper side thereof, opposite thechamber 111. Thus, an approximately central portion of the convex upper surface of theseptum 132 bulges through theaperture 128 and partially into theupper portion 124. - The
upper portion 124 of theclosure 114 defines thelateral slot 124 a therein. As mentioned above, and slot 124 a includes thefirst aperture 128 in the base thereof, connecting to theslot 122 a. At the upper end thereof, theslot 124 a defines asecond aperture 130, substantially vertically aligned with thefirst aperture 128, thereby exposing the firstpenetrable septum 132 for filling therethrough. Theslot 124 a also defines anopening 124 b in the sidewall thereof for receiving adisk 125 therethrough and into theslot 124 a. Thedisk 125 is shaped and configured to fit into and substantially mate with the corresponding interior shape of theslot 124 a. Thedisk 125 is dimensioned, relative to the interior dimensions of theslot 124 a, to create a dimensional interference therewith. For example, the thickness of theslot 124 a (perpendicular to the lateral extent of theslot 124 a) is slightly less than the thickness of thedisk 125, and therefore thedisk 125 creates an interference fit with theslot 124 a when inserted, e.g., wedged, therein. Thus, thedisk 125 forms a sliding, fluid-tight seal between itself and the interior surfaces of the walls of theslot 124 a when inserted therein. Thedisk 125 includes the secondpenetrable septum 134. Similar to the embodiment described above, the secondpenetrable septum 134 can be co-molded with thedisk 125. Alternatively, thesecond septum 134 can be over-molded onto thedisk 125. - The
disk 125 is initially inserted into theslot 124 a in a first position, as shown inFIG. 12B . In some embodiments, thedisk 125 is mechanically inserted into theslot 124 a, such as, for example, via a solenoid operated arm Thedisk 125 is movable, i.e., slideable, within theslot 124 a between the first position where thedisk 125 is positioned away from thefirst septum 132 bulging through thefirst aperture 128, and a second position (FIG. 12D ) where thedisk 125 is positioned between the first andsecond apertures second septum 134 overlies thefirst septum 132. In the first position, the portion of the upper surface of thefirst septum 132 bulging through thefirst aperture 132 is exposed to thesecond aperture 130 for filling therethrough. In the second position, thesecond septum 134 sealingly engages, i.e., overlies, the bulging portion of thefirst septum 132. The portion of thefirst septum 132 bulging partially into theslot 124 a narrows the thickness of theslot 124 a at that location within the slot, corresponding to the location of the second position of thedisk 125. Accordingly, when thedisk 125 is moved into the second position, thesecond septum 134 compresses against the bulging portion of thefirst septum 134, and, in turn, forms a mechanical compression seal therewith. The compression force on thedisk 125 andsecond septum 134 assists in maintaining the disk in the second position, e.g., by friction or wedging, during storage and subsequent use. - The assembled
device 110, i.e., thebody 112,closure 114,disk 125, first andsecond septums disk 125 in the first position, as shown inFIG. 12B . Sterilization of the device 100 may be performed in any of numerous different ways that are currently known, or that later become known, including without limitation, by the application of radiation thereto, such as e-beam, laser or UV radiation, by the application of a fluid sterilant, such as vaporized hydrogen peroxide (“VHP”) or nitric oxide (“NO”), or by heated gas in accordance with the teachings of any of the patents and patent applications incorporated by reference above. Once sterilized, the seal between thedisk 125 and theslot 124 a maintains the sterility of thesecond septum 134 therein. - With the
disk 125 in the first position, a filling device, such as the fillingdevice 60 disclosed above or in any of the patents and patent applications incorporated by reference above, can be advanced through thesecond aperture 130 to penetrate the firstpenetrable septum 132 and aseptically or sterile fill fluid into thesterile chamber 111 of the device 110 (FIG. 12C ). As described above, in some embodiments thefirst septum 132 wipes the tip of the filling member of contaminants thereon during engagement and penetration of theseptum 132 by the tip, to, in turn, prevent the tip from introducing such contaminants into the sterile interior of thechamber 111, thereby maintaining thechamber 111 and any substance therein aseptic or sterile. - After the
chamber 111 is filled as desired, the filling device is withdrawn from thefirst septum 132. Thefirst septum 132 can be engineered in a manner known to those of ordinary skill in the pertinent art to self-close and thereby ensure that the head loss left by the residual filling device injection aperture 196 after the tip of the filling device is withdrawn substantially prevents fluid ingress therethrough. Thereafter, thedisk 125 is slidably pressed from the first position into the second position (FIG. 12D ), such that the unpenetratedsecond septum 134 overlies and seals the injection aperture 196 in thefirst septum 132 from the ambient atmosphere in a similar manner as described in the above embodiment. Thedisk 125 surrounding thesecond septum 134 remains in sealing engagement with the interior surfaces of theslot 124 a. Prior to moving thesecond closure 124 from the first position to the second position, the bulging surface of thefirst closure 132 can be re-sterilized in order to prevent any contaminants from being trapped between the first andsecond septums - After the
device 110 has been filled and thedisk 125 has been moved into the second position, the openings of the filleddevice 110, such asopening 124 b, can be sealed, such as, for example, via shrink wrap, to provide an additional barrier. Similar to the embodiment ofdevice 10 described above, a tamper-proof layer 115 can be applied over theclosure 114 after filling. In the illustrated embodiment, the tamper-proof layer 115 is an adhesive-backed foil layer adhesively attached to theclosure 114, overlying thesecond aperture 130 and thesecond septum 134. In addition to sealing thesecond aperture 130, thefoil layer 115 also indicates whether thedevice 110 has been tampered with after filling thereof and prior to withdrawing the filled fluid therefrom. - When ready for use, a withdrawal device may penetrate or pierce through the first and
second septums chamber 111. In some embodiments, thesecond septum 134 is off-center within thedisk 125, so that a withdrawal device penetrating through thesecond septum 134, e.g., through the center thereof, can penetrate through thefirst septum 132 at a previously unpenetrated location and not through the injection aperture 196. - In
FIGS. 13-16 , another device is indicated generally by thereference numeral 210. Thedevice 210 is substantially similar to thedevice 110 described above in connection withFIGS. 11-12D , and therefore like reference numerals preceded by the numeral “2” are used to indicate like elements. A primary difference of thedevice 210 in comparison to thedevice 110 is the secondpenetrable septum 234 is large enough to sealingly cover the firstpenetrable septum 232 in both the first and the second positions, as hereinafter described. - As shown in
FIG. 13 , the secondpenetrable septum 234, within thedisk 225, includes afirst portion 234 a and asecond portion 234 b. In the first position of thedisk 225 within theslot 224 a, as shown inFIG. 14 , thefirst portion 234 a of thesecond septum 234 is positioned between the first andsecond apertures first septum 232 in similar manner as described above in the embodiment ofdevice 110. - The assembled device 210 (
FIG. 14 ), with thedisk 225 in the first position, can be sterilized prior to filling. Similar to the embodiment ofdevice 110 above, thedisk 225 creates a dimensional interference with theslot 224 a, thereby creating a sliding seal between thedisk 225 and theslot 224 a. The seal therebetween maintains the sterility of thesecond portion 234 b of thesecond septum 234 in the first position, i.e., during filling. Thereafter, as shown inFIG. 15 , a filling device, such as, for example, the fillingdevice 60, can be advanced through thesecond aperture 230, and, in turn, penetrate both thefirst portion 234 a of thesecond septum 234 and thefirst septum 232 to aseptically or sterile fill fluid into thesterile chamber 211 of thedevice 210. Similar to the embodiments ofdevices first portion 234 a of thesecond septum 234 and thefirst septum 232, in some embodiments, wipe the tip of the filling device of contaminants thereon during engagement and penetration of the septums thereby to, in turn, prevent the filling device from introducing such contaminants into the sterile interior of thechamber 211 and thereby maintain the chamber and any substance therein aseptic or sterile. - After the
chamber 211 is filled as desired and the filling device is withdrawn from thefirst septum 232 and, in turn, from thefirst portion 234 a of thesecond septum 234, thedisk 225 is slidably pressed from the first position (FIG. 15 ) into the second position (FIG. 16 ). Thefirst portion 234 a of thesecond septum 234 is sealed off from the remainder of thedevice 210 when thedisk 225 is moved from the first position into the second position. As shown, thefirst portion 234 a of theseptum 234 defines a substantially concave upper surface. Accordingly, in the second position, the portions of thedisk 225 and thesecond septum 234 surrounding thefirst portion 234 a of the second septum and sealingly engaging the interior surfaces of the upper and lower walls of theslot 224 a, trap, i.e., seal off, any contamination residing on thefirst portion 234 a in the pocket between the concave surface and the upper wall of theslot 224 a, e.g., from contact with and wiping of the tip of the fillingmember 60. - In the second position, as shown in
FIG. 16 , the sterile, unpenetratedsecond portion 234 b of thesecond septum 234 is positioned between the first andsecond apertures first septum 232. Thus, the fluid within thechamber 211 is hermetically sealed. Thefirst septum 232 is covered by thesecond septum 234 before, during and after penetration thereof, and thus the upper surface of thefirst septum 232 is never exposed to the ambient atmosphere and remains substantially sterile, particularly in embodiments where thesecond septum 234 wipes theinjection member 60. Therefore, no re-sterilization is required after filling. A needle or like withdrawal device can thereafter penetrate thesecond portion 234 b of thesecond septum 234 and thefirst septum 232 to withdraw liquid from thechamber 211, in a similar manner as described above. - In
FIGS. 17-18 , another device is indicated generally by thereference numeral 310. Thedevice 310 is substantially similar to thedevices FIGS. 11-16 , and therefore like reference numerals preceded by the numeral “3” are used to indicate like elements. A primary difference of thedevice 310 in comparison to thedevices device 310 includes a singlepenetrable septum 334. Theseptum 334 defines afirst portion 334 a for filling therethrough when thedisk 325 is located in the first position and asecond portion 334 b for sealing the contents of thedevice 310 and withdrawing substance therefrom when thedisk 325 is located in the second position, as hereinafter described. - As shown in
FIG. 17 , thedevice 310 comprises abody 312, aclosure 314 and adisk 325 including thepenetrable septum 334. Theclosure 314 is sealingly mounted atop the upper end of thebody 312. The upper rim of thebody 312 defines anannular spike 312 a that sealingly engages the base surface of theclosure 314. Theclosure 314 includes an annular, axially-extendingprojection 314 a, spaced radially inwardly relative to the perimeter of theclosure 314 and projecting axially downwardly from the base of theclosure 314. Theprojection 314 a is dimensioned to sealingly engage a portion of thebody sidewall 316 adjacent the opening 318 thereof. In some embodiments, the diameter of theprojection 314 a is dimensioned, relative to the outer diameter of thebody 312, to create a dimensional interference therewith, thereby creating a fluid-tight interference fit therebetween. - The
closure 314 defines alateral slot 324 a. Theslot 324 a defines afirst aperture 328 in the base end thereof, connecting theslot 324 a in fluid communication with thechamber 311 of thedevice 310. Theslot 324 a also defines asecond aperture 330 in the upper end thereof substantially vertically aligned with thefirst aperture 328. Theslot 324 a has anopening 324 b in the sidewall thereof for receiving thedisk 325, with thepenetrable septum 334, therethrough. Similar to the embodiments ofdevices disk 325 is shaped to mate with the corresponding interior shape of theslot 324 a and is dimensioned to create a dimensional interference therewith. Thus, thedisk 325 forms a sliding, fluid-tight seal between itself and the interior surfaces of theslot 324 a. - The
disk 325 is initially inserted into theslot 324 a into the first position, as shown inFIG. 18 . In the first position, thefirst portion 334 a of thepenetrable septum 334 is positioned between the first andsecond apertures device 310, with thedisk 325 in the first position, can be sterilized prior to filling. Once sterilized, the seal between thedisk 325 and theslot 324 a maintains the sterility of thesecond portion 324 b of theseptum 334 while in the first position, e.g., during filling. - As shown in
FIG. 19 , a filling device, such as, for example, the fillingdevice 60, can penetrate through thefirst portion 334 a of theseptum 334 as described above to aseptically or sterile fill fluid into thesterile chamber 311 of thedevice 310. Similar to the embodiments described above, theseptum 334, in some embodiments, wipes the tip of the filling device of contaminants thereon during engagement and penetration of the septum by the filling device to, in turn, prevent the filling device from introducing such contaminants into the sterile interior of thechamber 311. - After the
chamber 311 is filled as desired and the filling device is withdrawn from theseptum 334, thedisk 325 is slidingly pressed from the first position into the second position (FIG. 20 ), such that the sterile, unpenetratedsecond portion 334 b is positioned between the first andsecond apertures disk 325 and theslot 324 a, and because thesecond portion 334 b is unpenetrated, the fluid within thesterile chamber 311 is hermetically sealed. Thefirst portion 334 a of theseptum 334 is also sealed off from the remainder of thedevice 310 when thedisk 325 is moved from the first position into the second position. As shown, thefirst portion 334 a of theseptum 334 defines substantially concave upper and lower surfaces, which function similar to the concave surface of theseptum 234 ofdevice 210. Accordingly, in the second position, the portions of thedisk 325 and theseptum 334 surrounding thefirst portion 334 a of the septum and sealingly engaging the interior surfaces of theslot 324 a, trap, i.e., seal off, any contamination, such as liquid residue, residing on thefirst portion 334 a in the pockets between the concave surfaces of thefirst portion 334 a of theseptum 334 and the respective upper and lowers walls of theslot 324 a. - In
FIGS. 21-23 , another device is indicated generally by thereference numeral 410. Thedevice 410 is substantially similar to thedevices FIGS. 1-20 , and therefore like reference numerals preceded by the numeral “4” are used to indicate like elements. A primary difference of thedevice 410 in comparison to thedevices device 410 includes aclosure 414 that is rotatable relative to thebody 412 to selectively expose a fillingseptum 432 and awithdrawal septum 434, as hereinafter described. - As shown in
FIG. 21 , thedevice 410 includes abody 412, aseptum assembly 433, and aclosure 414. Theseptum assembly 433 comprises a penetrablebottom septum layer 433 a and an overlay layer 433 b. The overlay layer 433 b defines two apertures, receiving therein corresponding projections of theseptum layer 433 a to define apenetrable filling septum 432 and a separatepenetrable withdrawal septum 434. Theseptum layer 433 a, and thus the filling andwithdrawal septums septum assembly 433 is shaped and dimensioned to mount into theneck 413 and engage theflange 420 of thebody 412. The septum assembly includes diametricallyopposed tabs 433 c fittingly engageable with corresponding diametricallyopposed slots 413 a in theneck 413 of thebody 412. Thus, theseptum assembly 433 is not rotatable within theneck 413. Those of ordinary skill in the art should appreciate, though, that the septum assembly and neck may have fewer (e.g., one) or more two tabs and slots, respectively, which in any case need not be diametrically opposed, or no tabs/slots at all. - The
closure 414 mounts atop thebody 412 and forms a compression seal between theclosure 414, theseptum assembly 433, and thebody 412 in similar manner as described above with respect to the embodiment ofdevice 110. Theclosure 414 includes anaperture 428 in the upper surface thereof and is assembled onto thebody 412 in a first position or orientation relative to the septum assembly such that theaperture 428 is positioned above or over the fillingseptum 432, as shown inFIG. 22 . In the first position with the fillingseptum 432 exposed, the seal between theclosure 414 and the remainder of theseptum assembly 433 maintains the sterility of the remainder of theassembly 433. - The
closure 414 is rotatable about theneck 413 from the first position into a second position, to, in turn, position theaperture 428 abovewithdrawal septum 434, as shown inFIG. 23 . Due to the above-discussed compression seal, the seals between thebody 412,septum assembly 433, andclosure 414 are maintained during rotation. Once rotated into the second position, atab 433 d projecting upwardly from the overlay layer 433 b engages a corresponding slot or recess in the upper end of the closure 414 (not shown), thereby substantially preventing reverse rotation of theclosure 414 from the second position back toward the first position (or at least prevent inadvertent rotation). - Similar to the embodiments described above, the assembled
device 410 can be sterilized in like manner prior to filling. Thereafter, with theclosure 414 in the first position, a filling device, such as the fillingdevice 60 disclosed above or in any of the patents and patent applications incorporated by reference above, can be advanced through theaperture 428 to penetrate the fillingseptum 432 and aseptically or sterile fill fluid into thesterile chamber 411 of thedevice 410. As described above, in some embodiments the fillingseptum 432 wipes the tip of the filling member of contaminants thereon during engagement and penetration of theseptum 432 by the tip, to, in turn, prevent the tip from introducing such contaminants into the sterile interior of thechamber 411, thereby maintaining thechamber 411 and any substance therein aseptic or sterile. - After the
chamber 411 is filled as desired, the filling device is withdrawn from the fillingseptum 432. Theclosure 414 is then rotated into the second position, covering and sealing off the penetrated fillingseptum 432, thereby hermetically sealing the fluid within thesterile chamber 411. In the second position, the unpenetrated,sterile withdrawal septum 434 is exposed. A withdrawal device may thereafter penetrate through theseptum 434 to withdraw the fluid from thechamber 411. - As may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, numerous changes and modifications may be made to the above-described and other embodiments of the present invention without departing from its scope as defined in the claims. For example, the components of the container or other device and the filling device may be made of any of numerous different materials that are currently known, or that later become known, for performing the function(s) of each such component. Similarly, the components of the container or other device and filling device may take any of numerous different shapes and/or configurations. Also, the filling device may be used to inject any of numerous different types of fluids or other substances into the container or other device for any of numerous different applications, including, for example, medicaments, pharmaceuticals, vaccines, liquid nutrition products, supplements, and numerous other products that are currently known, or that later become known. Accordingly, this detailed description of embodiments is to be taken in an illustrative, as opposed to a limiting sense.
Claims (70)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/917,562 US20130333796A1 (en) | 2012-06-13 | 2013-06-13 | Device with penetrable septum, filling needle and penetrable closure, and related method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261659382P | 2012-06-13 | 2012-06-13 | |
US201361799744P | 2013-03-15 | 2013-03-15 | |
US13/917,562 US20130333796A1 (en) | 2012-06-13 | 2013-06-13 | Device with penetrable septum, filling needle and penetrable closure, and related method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20130333796A1 true US20130333796A1 (en) | 2013-12-19 |
Family
ID=49754808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/917,562 Abandoned US20130333796A1 (en) | 2012-06-13 | 2013-06-13 | Device with penetrable septum, filling needle and penetrable closure, and related method |
Country Status (12)
Country | Link |
---|---|
US (1) | US20130333796A1 (en) |
EP (1) | EP2861155A4 (en) |
JP (1) | JP2015519182A (en) |
KR (1) | KR20150034172A (en) |
CN (1) | CN104519805A (en) |
AU (1) | AU2013274132A1 (en) |
BR (1) | BR112014031326A2 (en) |
CA (1) | CA2876292A1 (en) |
CO (1) | CO7240420A2 (en) |
IN (1) | IN2014DN10606A (en) |
RU (1) | RU2015100517A (en) |
WO (1) | WO2013188703A1 (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120279177A1 (en) * | 2010-01-06 | 2012-11-08 | Hema | Method and device for processing containers |
EP2990031A1 (en) | 2014-08-28 | 2016-03-02 | Sun Pharmaceutical Industries Ltd | Parenteral dosage form of norepinephrine |
EP2992869A1 (en) | 2014-09-03 | 2016-03-09 | Sun Pharmaceutical Industries Ltd | Perfusion dosage form |
EP3000461A1 (en) | 2014-09-23 | 2016-03-30 | Sun Pharmaceutical Industries Ltd | Parenteral dosage form of amiodarone |
WO2016201200A1 (en) * | 2015-06-12 | 2016-12-15 | Csp Technologies, Inc. | Aseptic tamper evident sampling container |
CN106413784A (en) * | 2014-05-10 | 2017-02-15 | 皮博士研究所有限责任公司 | Self closing and opening filling needle, needle holder, filler and method |
US20170349335A1 (en) * | 2014-07-22 | 2017-12-07 | Aap Biomaterials Gmbh | Closure for pharmaceutical containers and method for sealing a bottle |
US9931274B2 (en) | 2015-09-15 | 2018-04-03 | Dr. Py Institute Llc | Septum that decontaminates by interaction with penetrating element |
USD829896S1 (en) | 2015-09-15 | 2018-10-02 | Dr. Py Institute Llc | Septum |
WO2019091622A1 (en) * | 2017-11-08 | 2019-05-16 | Robert Bosch Gmbh | Filling needle for dispensing a pharmaceutical liquid into a container and filling device |
IT201800003313A1 (en) * | 2018-03-06 | 2019-09-06 | Inge Spa | Bottle capping device for storing substances to be kept separate until their application and for taking the mixture obtained by syringe. |
US20200155759A1 (en) * | 2015-03-02 | 2020-05-21 | Amgen Inc. | Device and method for making aseptic connections |
CN111819437A (en) * | 2017-12-20 | 2020-10-23 | 色谱研究供应股份有限公司 | Diaphragm with chamber |
US20210259384A1 (en) * | 2020-02-25 | 2021-08-26 | The Gillette Company Llc | Storage assembly for a shaving razor system |
US11241379B2 (en) | 2015-12-01 | 2022-02-08 | Sun Pharmaceutical Industries Limited | Parenteral dosage form of diltiazem |
US11253642B2 (en) | 2016-02-09 | 2022-02-22 | Sun Pharmaceutical Industries Limited | Perfusion system |
WO2022058988A1 (en) | 2020-09-21 | 2022-03-24 | Sun Pharmaceutical Industries Limited | Parenteral dosage form of diltiazem |
US20220219843A1 (en) * | 2011-04-18 | 2022-07-14 | Dr. Py Institute, Llc | Needle with closure and method |
US11452439B2 (en) * | 2015-01-15 | 2022-09-27 | Covidien Lp | Device for accommodating surgical tool prior to and during medical procedures |
US11464707B2 (en) * | 2016-10-08 | 2022-10-11 | Fresenius Kabi Deutschland Gmbh | Connector for a medical package containing a liquid |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9415885B2 (en) | 2013-03-15 | 2016-08-16 | Dr. Py Institute Llc | Device with sliding stopper and related method |
EP3145561A1 (en) | 2014-05-20 | 2017-03-29 | Cequr SA | Medicine delivery device with restricted access filling port |
CN105151344B (en) * | 2015-09-14 | 2017-10-27 | 江苏新美星包装机械股份有限公司 | A kind of sterilized addition apparatus |
FR3044230B1 (en) | 2015-11-26 | 2021-04-02 | Commissariat Energie Atomique | DEVICE FOR MAKING A HERMETIC CONNECTION BETWEEN A NEEDLE AND A CONTAINER |
FR3105184B1 (en) * | 2019-12-20 | 2021-11-12 | Abc Transfer | REINFORCED WATERPROOF CONTAINER |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2364126A (en) * | 1941-12-09 | 1944-12-05 | Cantor Abraham | Receptacle closure |
US2395149A (en) * | 1944-09-11 | 1946-02-19 | John E B Shaw | Parenteral bottle construction |
US3637102A (en) * | 1970-05-25 | 1972-01-25 | Continental Can Co | Closures for aseptic filled containers |
US4671331A (en) * | 1986-03-13 | 1987-06-09 | Lyphomed, Inc. | Cover for medicinal vial |
US5632396A (en) * | 1993-05-06 | 1997-05-27 | Becton, Dickinson And Company | Combination stopper-shield closure |
US5679399A (en) * | 1987-07-17 | 1997-10-21 | Bio Barrier, Inc. | Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers |
US5931828A (en) * | 1996-09-04 | 1999-08-03 | The West Company, Incorporated | Reclosable vial closure |
US20060231519A1 (en) * | 2005-01-25 | 2006-10-19 | Daniel Py | Container closure with overlying needle penetrable and thermally resealable portion and underlying portion compatible with fat containing liquid product, and related method |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4834152A (en) * | 1986-02-27 | 1989-05-30 | Intelligent Medicine, Inc. | Storage receptacle sealing and transfer apparatus |
US7033339B1 (en) * | 1998-05-29 | 2006-04-25 | Becton Dickinson And Company (Part Interest) | Self sealing luer receiving stopcock |
US6902207B2 (en) * | 2002-05-01 | 2005-06-07 | Medtronic Minimed, Inc. | Self sealing disconnect device |
US7588724B2 (en) * | 2004-03-05 | 2009-09-15 | Bayer Healthcare Llc | Mechanical device for mixing a fluid sample with a treatment solution |
TWI243064B (en) * | 2004-05-21 | 2005-11-11 | Ming-Jeng Shiu | Injector for single use |
CN1988928A (en) * | 2004-07-27 | 2007-06-27 | 伊莱利利公司 | Multiple septum cartridge for medication dispensing device |
DE102004051300C5 (en) * | 2004-10-20 | 2013-01-24 | Fresenius Kabi Deutschland Gmbh | Cap for containers filled with medical fluids |
US7648491B2 (en) * | 2005-05-13 | 2010-01-19 | Bob Rogers | Medical substance transfer system |
KR20100100828A (en) * | 2007-10-26 | 2010-09-15 | 메디컬 인스틸 테크놀로지즈, 인코포레이티드 | Liquid nutrition product dispenser with plural product chambers for separate storage and intermixing prior to use, and related method |
WO2011006131A1 (en) * | 2009-07-09 | 2011-01-13 | Onpharma Inc. | Methods and apparatus for buffering parenteral solutions |
WO2012013585A1 (en) * | 2010-07-26 | 2012-02-02 | Sanofi-Aventis Deutschland Gmbh | Co-delivery of two medicaments in a single injection |
WO2013176587A1 (en) * | 2012-05-21 | 2013-11-28 | Carmel Pharma Ab | Protective cap |
-
2013
- 2013-06-13 US US13/917,562 patent/US20130333796A1/en not_active Abandoned
- 2013-06-13 AU AU2013274132A patent/AU2013274132A1/en not_active Abandoned
- 2013-06-13 JP JP2015517436A patent/JP2015519182A/en active Pending
- 2013-06-13 WO PCT/US2013/045732 patent/WO2013188703A1/en active Application Filing
- 2013-06-13 RU RU2015100517A patent/RU2015100517A/en not_active Application Discontinuation
- 2013-06-13 BR BR112014031326A patent/BR112014031326A2/en not_active IP Right Cessation
- 2013-06-13 EP EP13804794.9A patent/EP2861155A4/en not_active Withdrawn
- 2013-06-13 KR KR20157000849A patent/KR20150034172A/en not_active Application Discontinuation
- 2013-06-13 CA CA2876292A patent/CA2876292A1/en not_active Abandoned
- 2013-06-13 CN CN201380041304.6A patent/CN104519805A/en active Pending
-
2014
- 2014-12-12 IN IN10606DEN2014 patent/IN2014DN10606A/en unknown
-
2015
- 2015-01-06 CO CO15002165A patent/CO7240420A2/en unknown
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2364126A (en) * | 1941-12-09 | 1944-12-05 | Cantor Abraham | Receptacle closure |
US2395149A (en) * | 1944-09-11 | 1946-02-19 | John E B Shaw | Parenteral bottle construction |
US3637102A (en) * | 1970-05-25 | 1972-01-25 | Continental Can Co | Closures for aseptic filled containers |
US4671331A (en) * | 1986-03-13 | 1987-06-09 | Lyphomed, Inc. | Cover for medicinal vial |
US5679399A (en) * | 1987-07-17 | 1997-10-21 | Bio Barrier, Inc. | Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers |
US5632396A (en) * | 1993-05-06 | 1997-05-27 | Becton, Dickinson And Company | Combination stopper-shield closure |
US5931828A (en) * | 1996-09-04 | 1999-08-03 | The West Company, Incorporated | Reclosable vial closure |
US20060231519A1 (en) * | 2005-01-25 | 2006-10-19 | Daniel Py | Container closure with overlying needle penetrable and thermally resealable portion and underlying portion compatible with fat containing liquid product, and related method |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120279177A1 (en) * | 2010-01-06 | 2012-11-08 | Hema | Method and device for processing containers |
US9586801B2 (en) * | 2010-01-06 | 2017-03-07 | Hema | Method and device for processing containers |
US20220219843A1 (en) * | 2011-04-18 | 2022-07-14 | Dr. Py Institute, Llc | Needle with closure and method |
JP2017517453A (en) * | 2014-05-10 | 2017-06-29 | ドクター ピー インスティチュート エルエルシー | Self-opening and closing filling needle, needle holder, filler, and method |
US10850882B2 (en) | 2014-05-10 | 2020-12-01 | Dr. Py Institute Llc | Self closing and opening filling needle, needle holder, filler and method |
US10017286B2 (en) | 2014-05-10 | 2018-07-10 | Dr. Py Institute Llc | Self closing and opening filling needle, needle holder, filler and method |
CN106413784A (en) * | 2014-05-10 | 2017-02-15 | 皮博士研究所有限责任公司 | Self closing and opening filling needle, needle holder, filler and method |
US10293987B2 (en) * | 2014-07-22 | 2019-05-21 | Osartis Gmbh | Closure for pharmaceutical containers and method for sealing a bottle |
US20170349335A1 (en) * | 2014-07-22 | 2017-12-07 | Aap Biomaterials Gmbh | Closure for pharmaceutical containers and method for sealing a bottle |
US9877935B2 (en) | 2014-08-28 | 2018-01-30 | Sun Pharmaceutical Industries Limited | Parenteral dosage form of norepinephrine |
EP2990031A1 (en) | 2014-08-28 | 2016-03-02 | Sun Pharmaceutical Industries Ltd | Parenteral dosage form of norepinephrine |
US11166923B2 (en) | 2014-08-28 | 2021-11-09 | Sun Pharmaceutical Industries Limited | Parenteral dosage form of norepinephrine |
US10098813B2 (en) | 2014-09-03 | 2018-10-16 | Sun Pharmaceutical Industries Limited | Perfusion dosage form |
EP3363428A1 (en) | 2014-09-03 | 2018-08-22 | Sun Pharmaceutical Industries Ltd | Perfusion dosage form |
US11793719B2 (en) | 2014-09-03 | 2023-10-24 | Sun Pharmaceutical Industries Limited | Perfusion dosage form |
EP2992869A1 (en) | 2014-09-03 | 2016-03-09 | Sun Pharmaceutical Industries Ltd | Perfusion dosage form |
EP3000461A1 (en) | 2014-09-23 | 2016-03-30 | Sun Pharmaceutical Industries Ltd | Parenteral dosage form of amiodarone |
US11452439B2 (en) * | 2015-01-15 | 2022-09-27 | Covidien Lp | Device for accommodating surgical tool prior to and during medical procedures |
US20200155759A1 (en) * | 2015-03-02 | 2020-05-21 | Amgen Inc. | Device and method for making aseptic connections |
US11119010B2 (en) * | 2015-06-12 | 2021-09-14 | Csp Technologies, Inc. | Aseptic tamper evident sampling container |
WO2016201200A1 (en) * | 2015-06-12 | 2016-12-15 | Csp Technologies, Inc. | Aseptic tamper evident sampling container |
US9931274B2 (en) | 2015-09-15 | 2018-04-03 | Dr. Py Institute Llc | Septum that decontaminates by interaction with penetrating element |
US10688020B2 (en) | 2015-09-15 | 2020-06-23 | Dr. Py Institute Llc | Septum that decontaminates by interaction with penetrating element |
USD829896S1 (en) | 2015-09-15 | 2018-10-02 | Dr. Py Institute Llc | Septum |
US11241379B2 (en) | 2015-12-01 | 2022-02-08 | Sun Pharmaceutical Industries Limited | Parenteral dosage form of diltiazem |
US11253642B2 (en) | 2016-02-09 | 2022-02-22 | Sun Pharmaceutical Industries Limited | Perfusion system |
US11464707B2 (en) * | 2016-10-08 | 2022-10-11 | Fresenius Kabi Deutschland Gmbh | Connector for a medical package containing a liquid |
US10799636B2 (en) | 2017-11-08 | 2020-10-13 | Syntegon Technology Gmbh | Filling needle for dispensing a pharmaceutical liquid into a container, and filling device |
WO2019091622A1 (en) * | 2017-11-08 | 2019-05-16 | Robert Bosch Gmbh | Filling needle for dispensing a pharmaceutical liquid into a container and filling device |
CN111819437A (en) * | 2017-12-20 | 2020-10-23 | 色谱研究供应股份有限公司 | Diaphragm with chamber |
EP3536631A1 (en) * | 2018-03-06 | 2019-09-11 | INGE S.p.A. | Device for capping a bottle suited to the preservation of substances to be kept separate until their application and suited to the collection of the mixture obtained by means of a syringe |
IT201800003313A1 (en) * | 2018-03-06 | 2019-09-06 | Inge Spa | Bottle capping device for storing substances to be kept separate until their application and for taking the mixture obtained by syringe. |
US20210259384A1 (en) * | 2020-02-25 | 2021-08-26 | The Gillette Company Llc | Storage assembly for a shaving razor system |
WO2022058988A1 (en) | 2020-09-21 | 2022-03-24 | Sun Pharmaceutical Industries Limited | Parenteral dosage form of diltiazem |
Also Published As
Publication number | Publication date |
---|---|
CA2876292A1 (en) | 2013-12-19 |
CO7240420A2 (en) | 2015-04-17 |
EP2861155A1 (en) | 2015-04-22 |
WO2013188703A1 (en) | 2013-12-19 |
CN104519805A (en) | 2015-04-15 |
BR112014031326A2 (en) | 2017-06-27 |
AU2013274132A1 (en) | 2015-01-22 |
JP2015519182A (en) | 2015-07-09 |
IN2014DN10606A (en) | 2015-09-11 |
KR20150034172A (en) | 2015-04-02 |
RU2015100517A (en) | 2016-08-10 |
EP2861155A4 (en) | 2016-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20130333796A1 (en) | Device with penetrable septum, filling needle and penetrable closure, and related method | |
US20190032831A1 (en) | Self closing connector | |
US20180363819A1 (en) | Device for connecting or filling and method | |
US20220219843A1 (en) | Needle with closure and method | |
US10351271B2 (en) | Device for connecting or filling and method | |
EP2608758B1 (en) | Assembly to facilitate user reconstitution | |
US9415885B2 (en) | Device with sliding stopper and related method | |
JP2017517453A (en) | Self-opening and closing filling needle, needle holder, filler, and method | |
CN114246794A (en) | Nutrient substance device | |
US10500132B2 (en) | Pouch with sealed fitment and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DR. PY INSTITUTE LLC, CONNECTICUT Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PY, DANIEL;REEL/FRAME:032847/0268 Effective date: 20140312 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: OHM LABORATORIES, INC., NEW JERSEY Free format text: SECURITY INTEREST;ASSIGNORS:MEDINSTILL DEVELOPMENT LLC;DR PY INSTITUTE LLC;INTACT PUR-NEEDLE LLC;AND OTHERS;REEL/FRAME:066641/0831 Effective date: 20240130 Owner name: SUN PHARMACEUTICAL INDUSTRIES, INC., NEW JERSEY Free format text: SECURITY INTEREST;ASSIGNORS:MEDINSTILL DEVELOPMENT LLC;DR PY INSTITUTE LLC;INTACT PUR-NEEDLE LLC;AND OTHERS;REEL/FRAME:066641/0831 Effective date: 20240130 |